<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" media="screen" href="/~d/styles/atom10full.xsl"?><?xml-stylesheet type="text/css" media="screen" href="http://feeds.feedburner.com/~d/styles/itemcontent.css"?><feed xmlns="http://www.w3.org/2005/Atom" xmlns:openSearch="http://a9.com/-/spec/opensearch/1.1/" xmlns:georss="http://www.georss.org/georss" xmlns:gd="http://schemas.google.com/g/2005" xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" gd:etag="W/&quot;Dk8CR3czfSp7ImA9WxBTEkw.&quot;"><id>tag:blogger.com,1999:blog-2057269305378114997</id><updated>2009-12-07T14:41:06.985-05:00</updated><title>Allergy Notes</title><subtitle type="html">Allergy, Asthma &amp;amp; Immunology News Updated Daily: The Blog of &lt;a href="http://allergycases.org/"&gt;AllergyCases.org&lt;/a&gt;</subtitle><link rel="http://schemas.google.com/g/2005#feed" type="application/atom+xml" href="http://allergynotes.blogspot.com/feeds/posts/default" /><link rel="alternate" type="text/html" href="http://allergynotes.blogspot.com/" /><link rel="hub" href="http://pubsubhubbub.appspot.com/" /><link rel="next" type="application/atom+xml" href="http://www.blogger.com/feeds/2057269305378114997/posts/default?start-index=26&amp;max-results=25&amp;redirect=false&amp;v=2" /><author><name>Ves Dimov, M.D.</name><email>noreply@blogger.com</email></author><generator version="7.00" uri="http://www.blogger.com">Blogger</generator><openSearch:totalResults>650</openSearch:totalResults><openSearch:startIndex>1</openSearch:startIndex><openSearch:itemsPerPage>25</openSearch:itemsPerPage><link rel="self" href="http://feeds.feedburner.com/AllergyNotes" type="application/atom+xml" /><feedburner:emailServiceId>AllergyNotes</feedburner:emailServiceId><feedburner:feedburnerHostname>http://feedburner.google.com</feedburner:feedburnerHostname><feedburner:feedFlare href="http://add.my.yahoo.com/rss?url=http%3A%2F%2Ffeeds.feedburner.com%2FAllergyNotes" src="http://us.i1.yimg.com/us.yimg.com/i/us/my/addtomyyahoo4.gif">Subscribe with My Yahoo!</feedburner:feedFlare><feedburner:feedFlare href="http://www.newsgator.com/ngs/subscriber/subext.aspx?url=http%3A%2F%2Ffeeds.feedburner.com%2FAllergyNotes" src="http://www.newsgator.com/images/ngsub1.gif">Subscribe with NewsGator</feedburner:feedFlare><feedburner:feedFlare href="http://feeds.my.aol.com/add.jsp?url=http%3A%2F%2Ffeeds.feedburner.com%2FAllergyNotes" src="http://o.aolcdn.com/favorites.my.aol.com/webmaster/ffclient/webroot/locale/en-US/images/myAOLButtonSmall.gif">Subscribe with My AOL</feedburner:feedFlare><feedburner:feedFlare href="http://www.bloglines.com/sub/http://feeds.feedburner.com/AllergyNotes" src="http://www.bloglines.com/images/sub_modern11.gif">Subscribe with Bloglines</feedburner:feedFlare><feedburner:feedFlare href="http://www.netvibes.com/subscribe.php?url=http%3A%2F%2Ffeeds.feedburner.com%2FAllergyNotes" src="http://www.netvibes.com/img/add2netvibes.gif">Subscribe with Netvibes</feedburner:feedFlare><feedburner:feedFlare href="http://fusion.google.com/add?feedurl=http%3A%2F%2Ffeeds.feedburner.com%2FAllergyNotes" src="http://buttons.googlesyndication.com/fusion/add.gif">Subscribe with Google</feedburner:feedFlare><feedburner:feedFlare href="http://www.pageflakes.com/subscribe.aspx?url=http%3A%2F%2Ffeeds.feedburner.com%2FAllergyNotes" src="http://www.pageflakes.com/ImageFile.ashx?instanceId=Static_4&amp;fileName=ATP_blu_91x17.gif">Subscribe with Pageflakes</feedburner:feedFlare><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="hub" href="http://pubsubhubbub.appspot.com" /><entry gd:etag="W/&quot;CkMCQX89eCp7ImA9WxBTEk0.&quot;"><id>tag:blogger.com,1999:blog-2057269305378114997.post-6622252389993518118</id><published>2009-12-07T10:41:00.001-05:00</published><updated>2009-12-07T10:41:00.160-05:00</updated><app:edited xmlns:app="http://www.w3.org/2007/app">2009-12-07T10:41:00.160-05:00</app:edited><category scheme="http://www.blogger.com/atom/ns#" term="News of the Day" /><title>Allergy and Immunology News of the Day</title><content type="html">&lt;a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="http://3.bp.blogspot.com/_LY7APi0bufs/SXFDHrotv1I/AAAAAAAADTg/Jq_g36NjLeg/s1600-h/Clock-2-small.jpg"&gt;&lt;img style="margin: 0pt 0pt 10px 10px; float: right; cursor: pointer; width: 100px; height: 100px;" src="http://3.bp.blogspot.com/_LY7APi0bufs/SXFDHrotv1I/AAAAAAAADTg/Jq_g36NjLeg/s200/Clock-2-small.jpg" alt="" id="BLOGGER_PHOTO_ID_5292084836388683602" border="0" /&gt;&lt;/a&gt; &lt;a href="http://casesblog.blogspot.com/search/label/Health%20News%20of%20the%20Day"&gt;Health News of the Day&lt;/a&gt; is a daily summary made from the &lt;a href="https://twitter.com/Allergy"&gt;selected links I post on Twitter&lt;/a&gt;. It is in a bullet points format with links to the original sources which include 350 RSS feeds that produce about 2,500 items per day.&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;&lt;/span&gt;&lt;/span&gt;&lt;blockquote&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;Combination budesonide/formoterol produced a greater improvement in lung function than budesonide MDI alone &lt;a href="http://bit.ly/3BdMVs" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/3BdMVs&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;Only 29% of parents removed their animals from home after allergist told them to do so for their child's health &lt;a href="http://bit.ly/46HvCJ" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/46HvCJ&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;Literature review: No signs of a declining trend in asthma prevalence &lt;a href="http://bit.ly/3HjEDy" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/3HjEDy&lt;/a&gt; - Google Trends tells a different story however.&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;Fatal reactions to SCIT may be on the decline, 6 fatalities between 2001 and 2007 &lt;a href="http://bit.ly/2yzWF7" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/2yzWF7&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;Ovomucoid is the major allergen of egg, strict avoidance is the key in management &lt;a href="http://bit.ly/2Q6mbQ" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/2Q6mbQ&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;Relationship between hormones and asthma: oral contraceptives may reduce asthma symptoms &lt;a href="http://bit.ly/3AtGrM" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/3AtGrM&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;HRCT is an important diagnostic tool for pulmonary complications in CVID at the time of diagnosis and during follow-up &lt;a href="http://bit.ly/30Z4C4" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/30Z4C4&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;Tricyclic antidepressants should be withheld for 2 to 3 days before allergy skin testing to avoid interference &lt;a href="http://bit.ly/1I442X" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/1I442X&lt;/a&gt;&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;Lung function at 10 yrs is not improved by early corticosteroid treatment in asthmatic children &lt;a href="http://bit.ly/3dfhj4" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/3dfhj4&lt;/a&gt;&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;Treating asthmatic children with montelukast (Singulair) appears effective - the study was sponsored by Merck  &lt;a href="http://bit.ly/3Fu5tF" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/3Fu5tF&lt;/a&gt;&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;/blockquote&gt;Medical news tweets are not research articles - they are 140-character messages - please always go to the original source, links, etc. Tweets and links do not represent endorsement, approval or support. Image source: OpenClipArt.org, public domain.&lt;br /&gt;&lt;br /&gt;&lt;a href="http://twitter.com/Allergy"&gt;Follow me&lt;/a&gt; on Twitter:&lt;br /&gt;&lt;br /&gt;&lt;script type="text/javascript" language="JavaScript" src="http://twittercounter.com/embed/?username=Allergy&amp;amp;style=bird"&gt;&lt;/script&gt;&lt;span style="font-weight: bold;"&gt;&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;p&gt;   &lt;/p&gt;

Posted at &lt;a href="http://allergynotes.blogspot.com/"&gt;Allergy Notes&lt;/a&gt;. Stay updated and &lt;a href="http://feeds.feedburner.com/AllergyNotes"&gt;subscribe&lt;/a&gt;, or follow me on &lt;a href="http://twitter.com/Allergy"&gt;Twitter&lt;/a&gt;.&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2057269305378114997-6622252389993518118?l=allergynotes.blogspot.com' alt='' /&gt;&lt;/div&gt;
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/PPLavjeohYdXVSB5-HDeFbxwKP8/0/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/PPLavjeohYdXVSB5-HDeFbxwKP8/0/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;br/&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/PPLavjeohYdXVSB5-HDeFbxwKP8/1/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/PPLavjeohYdXVSB5-HDeFbxwKP8/1/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/AllergyNotes/~4/fjlm1PeQ2R0" height="1" width="1"/&gt;</content><link rel="replies" type="application/atom+xml" href="http://allergynotes.blogspot.com/feeds/6622252389993518118/comments/default" title="Post Comments" /><link rel="replies" type="text/html" href="http://allergynotes.blogspot.com/2009/12/allergy-and-immunology-news-of-day_07.html#comment-form" title="0 Comments" /><link rel="edit" type="application/atom+xml" href="http://www.blogger.com/feeds/2057269305378114997/posts/default/6622252389993518118?v=2" /><link rel="self" type="application/atom+xml" href="http://www.blogger.com/feeds/2057269305378114997/posts/default/6622252389993518118?v=2" /><link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/AllergyNotes/~3/fjlm1PeQ2R0/allergy-and-immunology-news-of-day_07.html" title="Allergy and Immunology News of the Day" /><author><name>Ves Dimov, M.D.</name><email>noreply@blogger.com</email><gd:extendedProperty name="OpenSocialUserId" value="07511862151701001787" /></author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="http://3.bp.blogspot.com/_LY7APi0bufs/SXFDHrotv1I/AAAAAAAADTg/Jq_g36NjLeg/s72-c/Clock-2-small.jpg" height="72" width="72" /><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total><feedburner:origLink>http://allergynotes.blogspot.com/2009/12/allergy-and-immunology-news-of-day_07.html</feedburner:origLink></entry><entry gd:etag="W/&quot;D0ICQX8zfSp7ImA9WxBTEUo.&quot;"><id>tag:blogger.com,1999:blog-2057269305378114997.post-7918694061222545498</id><published>2009-12-07T03:46:00.001-05:00</published><updated>2009-12-07T03:46:00.185-05:00</updated><app:edited xmlns:app="http://www.w3.org/2007/app">2009-12-07T03:46:00.185-05:00</app:edited><category scheme="http://www.blogger.com/atom/ns#" term="Rhinitis" /><category scheme="http://www.blogger.com/atom/ns#" term="Nasal Irrigation" /><title>Saline Nasal Irrigation: 2009 Review</title><content type="html">From AFP and &lt;a href="http://www.medscape.com/viewarticle/713108?src=rss"&gt;Medscape&lt;/a&gt;:&lt;br /&gt;&lt;br /&gt;Saline nasal irrigation bathes the nasal cavity with liquid or spray by instilling saline into 1 nostril and allowing it to drain out of the other nostril (typically, it drains from both nostrils and the mouth - author's note).&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;&lt;b&gt;Techniques and devices&lt;/b&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;Techniques and devices include:&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;- low positive pressure from a spray or squirt bottle&lt;/div&gt;&lt;div&gt;- gravity-based pressure using a neti pot or other vessel with a nasal spout&lt;br /&gt;&lt;br /&gt;&lt;object width="425" height="344"&gt;&lt;param name="movie" value="http://www.youtube.com/v/LW9mvVe7Mk4&amp;amp;color1=0xb1b1b1&amp;amp;color2=0xcfcfcf&amp;amp;fs=1"&gt;&lt;param name="allowFullScreen" value="true"&gt;&lt;embed src="http://www.youtube.com/v/LW9mvVe7Mk4&amp;amp;color1=0xb1b1b1&amp;amp;color2=0xcfcfcf&amp;amp;fs=1" type="application/x-shockwave-flash" allowfullscreen="true" width="425" height="344"&gt;&lt;/embed&gt;&lt;/object&gt;&lt;br /&gt;SinusRinse video.&lt;br /&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;&lt;b&gt;Solution concentration&lt;/b&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;0.9% (normal saline) to 3% (hypertonic) saline solutions are used. Optimal salinity (solution concentration), pH, and temperature are unknown.&lt;br /&gt;&lt;br /&gt;Nasal irrigation may be helpful to manage symptoms of chronic rhinosinusitis (symptoms for more than 12 weeks) and this is the most common indication.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;In one study, daily use of 2% liquid (not spray) was associated with a 64% reduction in symptom severity vs routine care alone.&lt;br /&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;&lt;b&gt;Indications&lt;/b&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;A range of conditions may respond to saline nasal irrigation but the evidence supporting its use is less conclusive:&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;- allergic rhinitis &lt;/div&gt;&lt;div&gt;- acute upper respiratory tract infections (URTI)&lt;/div&gt;&lt;div&gt;- rhinitis of pregnancy&lt;/div&gt;&lt;div&gt;- acute rhinosinusitis&lt;/div&gt;&lt;div&gt;&lt;br /&gt;The exact mechanism of action of saline nasal irrigation is unknown. Saline nasal irrigation may improve nasal mucosa function through direct cleansing; removal of inflammatory mediators, and improved mucociliary function, as suggested by increased ciliary beat frequency.&lt;br /&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;&lt;b&gt;Adverse effects&lt;/b&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;Fewer than 10% of patients reported adverse effects:&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;- self-limited sensation of ear fullness&lt;/div&gt;&lt;div&gt;- "stinging" of the nasal mucosa&lt;/div&gt;&lt;div&gt;- rarely epistaxis&lt;br /&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;&lt;b&gt;Contraindications&lt;/b&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;Contraindications for saline nasal irrigation include:&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;- incompletely healed facial trauma&lt;/div&gt;&lt;div&gt;- increased risk for aspiration, such as intention tremor or other neurologic or musculoskeletal problems.&lt;br /&gt;&lt;br /&gt;&lt;b&gt;Recommendations&lt;/b&gt;&lt;br /&gt;&lt;br /&gt;- For chronic rhinosinusitis, nasal irrigation is an effective adjunctive therapy (level of evidence, A).&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;- Limited evidence for effective adjunctive treatment of irritant or allergic rhinitis, viral upper respiratory tract infection, and postoperative care after endoscopic sinus surgery (level of evidence, B).&lt;/div&gt;&lt;div&gt;&lt;br /&gt;- rhinitis of pregnancy, acute rhinosinusitis, sinonasal sarcoidosis, and Wegener's granulomatosis (level of evidence, C).&lt;br /&gt;&lt;br /&gt;References:&lt;br /&gt;&lt;a href="http://www.medscape.com/viewarticle/713108?src=rss"&gt;Use of Saline Nasal Irrigation Reviewed&lt;/a&gt;. Laurie Barclay, MD. Medscape, 2009.&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;p&gt;   &lt;/p&gt;

Posted at &lt;a href="http://allergynotes.blogspot.com/"&gt;Allergy Notes&lt;/a&gt;. Stay updated and &lt;a href="http://feeds.feedburner.com/AllergyNotes"&gt;subscribe&lt;/a&gt;, or follow me on &lt;a href="http://twitter.com/Allergy"&gt;Twitter&lt;/a&gt;.&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2057269305378114997-7918694061222545498?l=allergynotes.blogspot.com' alt='' /&gt;&lt;/div&gt;
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/9_AlYVCWBJ0A9jTbMQ1H99VswEw/0/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/9_AlYVCWBJ0A9jTbMQ1H99VswEw/0/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;br/&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/9_AlYVCWBJ0A9jTbMQ1H99VswEw/1/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/9_AlYVCWBJ0A9jTbMQ1H99VswEw/1/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/AllergyNotes/~4/HYEPNChm7f0" height="1" width="1"/&gt;</content><link rel="replies" type="application/atom+xml" href="http://allergynotes.blogspot.com/feeds/7918694061222545498/comments/default" title="Post Comments" /><link rel="replies" type="text/html" href="http://allergynotes.blogspot.com/2009/12/saline-nasal-irrigation-2009-review.html#comment-form" title="0 Comments" /><link rel="edit" type="application/atom+xml" href="http://www.blogger.com/feeds/2057269305378114997/posts/default/7918694061222545498?v=2" /><link rel="self" type="application/atom+xml" href="http://www.blogger.com/feeds/2057269305378114997/posts/default/7918694061222545498?v=2" /><link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/AllergyNotes/~3/HYEPNChm7f0/saline-nasal-irrigation-2009-review.html" title="Saline Nasal Irrigation: 2009 Review" /><author><name>Ves Dimov, M.D.</name><email>noreply@blogger.com</email><gd:extendedProperty name="OpenSocialUserId" value="07511862151701001787" /></author><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total><feedburner:origLink>http://allergynotes.blogspot.com/2009/12/saline-nasal-irrigation-2009-review.html</feedburner:origLink></entry><entry gd:etag="W/&quot;DUMGQX84eyp7ImA9WxBTEE8.&quot;"><id>tag:blogger.com,1999:blog-2057269305378114997.post-3693027370154790793</id><published>2009-12-05T10:37:00.001-05:00</published><updated>2009-12-05T10:37:00.133-05:00</updated><app:edited xmlns:app="http://www.w3.org/2007/app">2009-12-05T10:37:00.133-05:00</app:edited><category scheme="http://www.blogger.com/atom/ns#" term="News of the Day" /><title>Allergy and Immunology News of the Day</title><content type="html">&lt;a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="http://3.bp.blogspot.com/_LY7APi0bufs/SXFDHrotv1I/AAAAAAAADTg/Jq_g36NjLeg/s1600-h/Clock-2-small.jpg"&gt;&lt;img style="margin: 0pt 0pt 10px 10px; float: right; cursor: pointer; width: 100px; height: 100px;" src="http://3.bp.blogspot.com/_LY7APi0bufs/SXFDHrotv1I/AAAAAAAADTg/Jq_g36NjLeg/s200/Clock-2-small.jpg" alt="" id="BLOGGER_PHOTO_ID_5292084836388683602" border="0" /&gt;&lt;/a&gt; &lt;a href="http://casesblog.blogspot.com/search/label/Health%20News%20of%20the%20Day"&gt;Health News of the Day&lt;/a&gt; is a daily summary made from the &lt;a href="https://twitter.com/Allergy"&gt;selected links I post on Twitter&lt;/a&gt;. It is in a bullet points format with links to the original sources which include 350 RSS feeds that produce about 2,500 items per day.&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;&lt;/span&gt;&lt;/span&gt;&lt;blockquote&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;The Buteyko method: A Breathing Technique Offers Help for People With Asthma &lt;a href="http://bit.ly/3ueFU" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/3ueFU&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;Early trials of anti-IL-13 therapies in asthma have shown promise, results of further efficacy studies are awaited &lt;a href="http://bit.ly/1mZZsC" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/1mZZsC&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;Vinegar addition during the cooking process may decrease lentil and chicken allergenicity &lt;a href="http://bit.ly/1cqOQC" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/1cqOQC&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;Subcutaneous allergen immunotherapy restores dendritic cell innate immune function &lt;a href="http://bit.ly/YAcWI" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/YAcWI&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;Paracetamol might be a risk factor for the development of asthma &lt;a href="http://bit.ly/4BPdL" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/4BPdL&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;Asthma associated with more sweating during exercise in boys, and ICS decrease the amount of sweating &lt;a href="http://bit.ly/2E2SJT" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/2E2SJT&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;Potential treatment for priapism (painful erections longer than 4 hours): adenosine deaminase used for SCID therapy &lt;a href="http://bit.ly/1QgPUf" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/1QgPUf&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;Treatment of psoriasis with etanercept is linked to suppression of IL-17 signaling &lt;a href="http://bit.ly/1E3ssJ" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/1E3ssJ&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;Epicutaneous allergen administration as a novel method of allergen-specific immunotherapy, different approach from SCIT &lt;a href="http://bit.ly/2CogxY" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/2CogxY&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;Asociation between antibiotic use in the first year of life and asthma, rhinoconjunctivitis, eczema at 6-7 years old &lt;a href="http://bit.ly/2CZ0ZE" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/2CZ0ZE&lt;/a&gt;&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/blockquote&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;Medical news tweets are not research articles - they are 140-character messages - please always go to the original source, links, etc. Tweets and links do not represent endorsement, approval or support. Image source: OpenClipArt.org, public domain.&lt;br /&gt;&lt;br /&gt;&lt;a href="http://twitter.com/Allergy"&gt;Follow me&lt;/a&gt; on Twitter:&lt;br /&gt;&lt;br /&gt;&lt;script type="text/javascript" language="JavaScript" src="http://twittercounter.com/embed/?username=Allergy&amp;amp;style=bird"&gt;&lt;/script&gt;&lt;span style="font-weight: bold;"&gt;&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;p&gt;   &lt;/p&gt;

Posted at &lt;a href="http://allergynotes.blogspot.com/"&gt;Allergy Notes&lt;/a&gt;. Stay updated and &lt;a href="http://feeds.feedburner.com/AllergyNotes"&gt;subscribe&lt;/a&gt;, or follow me on &lt;a href="http://twitter.com/Allergy"&gt;Twitter&lt;/a&gt;.&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2057269305378114997-3693027370154790793?l=allergynotes.blogspot.com' alt='' /&gt;&lt;/div&gt;
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/snL6ROmhyugGf4iEH4AtR8N3-Yk/0/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/snL6ROmhyugGf4iEH4AtR8N3-Yk/0/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;br/&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/snL6ROmhyugGf4iEH4AtR8N3-Yk/1/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/snL6ROmhyugGf4iEH4AtR8N3-Yk/1/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/AllergyNotes/~4/QsecSrXoqHk" height="1" width="1"/&gt;</content><link rel="replies" type="application/atom+xml" href="http://allergynotes.blogspot.com/feeds/3693027370154790793/comments/default" title="Post Comments" /><link rel="replies" type="text/html" href="http://allergynotes.blogspot.com/2009/12/allergy-and-immunology-news-of-day_05.html#comment-form" title="0 Comments" /><link rel="edit" type="application/atom+xml" href="http://www.blogger.com/feeds/2057269305378114997/posts/default/3693027370154790793?v=2" /><link rel="self" type="application/atom+xml" href="http://www.blogger.com/feeds/2057269305378114997/posts/default/3693027370154790793?v=2" /><link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/AllergyNotes/~3/QsecSrXoqHk/allergy-and-immunology-news-of-day_05.html" title="Allergy and Immunology News of the Day" /><author><name>Ves Dimov, M.D.</name><email>noreply@blogger.com</email><gd:extendedProperty name="OpenSocialUserId" value="07511862151701001787" /></author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="http://3.bp.blogspot.com/_LY7APi0bufs/SXFDHrotv1I/AAAAAAAADTg/Jq_g36NjLeg/s72-c/Clock-2-small.jpg" height="72" width="72" /><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total><feedburner:origLink>http://allergynotes.blogspot.com/2009/12/allergy-and-immunology-news-of-day_05.html</feedburner:origLink></entry><entry gd:etag="W/&quot;CkMMQXY_fip7ImA9WxNaGUk.&quot;"><id>tag:blogger.com,1999:blog-2057269305378114997.post-382515139962205147</id><published>2009-12-04T10:28:00.002-05:00</published><updated>2009-12-04T10:28:00.846-05:00</updated><app:edited xmlns:app="http://www.w3.org/2007/app">2009-12-04T10:28:00.846-05:00</app:edited><category scheme="http://www.blogger.com/atom/ns#" term="News of the Day" /><title>Allergy and Immunology News of the Day</title><content type="html">&lt;a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="http://3.bp.blogspot.com/_LY7APi0bufs/SXFDHrotv1I/AAAAAAAADTg/Jq_g36NjLeg/s1600-h/Clock-2-small.jpg"&gt;&lt;img style="margin: 0pt 0pt 10px 10px; float: right; cursor: pointer; width: 100px; height: 100px;" src="http://3.bp.blogspot.com/_LY7APi0bufs/SXFDHrotv1I/AAAAAAAADTg/Jq_g36NjLeg/s200/Clock-2-small.jpg" alt="" id="BLOGGER_PHOTO_ID_5292084836388683602" border="0" /&gt;&lt;/a&gt; &lt;a href="http://casesblog.blogspot.com/search/label/Health%20News%20of%20the%20Day"&gt;Health News of the Day&lt;/a&gt; is a daily summary made from the &lt;a href="https://twitter.com/Allergy"&gt;selected links I post on Twitter&lt;/a&gt;. It is in a bullet points format with links to the original sources which include 350 RSS feeds that produce about 2,500 items per day.&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;&lt;/span&gt;&lt;/span&gt;&lt;blockquote&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;T Helper 17 Cells Promote Cytotoxic T Cell Activation in Tumor Immunity &lt;a href="http://bit.ly/1I4XYC" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/1I4XYC&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;Pertussis (Whooping Cough) Immunity May Last 30 Years or More &lt;a href="http://bit.ly/18M8m1" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/18M8m1&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;The viral march: a connection between early life wheezing and subsequent asthma &lt;a href="http://bit.ly/2oFgMw" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/2oFgMw&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;Budesonide may decrease episodes of wheezing in infants/preschoolers with recurrent wheezing, independently of atopy &lt;a href="http://bit.ly/1wNIqS" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/1wNIqS&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;24 million in US have COPD, but only half know it. Follow NHLBI campaign at &lt;a href="http://bit.ly/29IOOp" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/29IOOp&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;Beneficial effect of grass allergy immunotherapy tablet on rhinoconjunctivitis quality of life &lt;a href="http://bit.ly/2aP0c4" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/2aP0c4&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;RSS feeds of all Allergy and Immunology journals by the University of Wisconsin &lt;a href="http://bit.ly/1QQpQg" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/1QQpQg&lt;/a&gt; and &lt;a href="http://bit.ly/4zxxdg" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/4zxxdg&lt;/a&gt; -- &lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;(better view) &lt;a href="http://bit.ly/4C9KeM" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/4C9KeM&lt;/a&gt;&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;My list of allergists on Twitter - please reply to this tweet if you want to be included &lt;a href="http://bit.ly/2QJLK7" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/2QJLK7&lt;/a&gt;&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/blockquote&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;Medical news tweets are not research articles - they are 140-character messages - please always go to the original source, links, etc. Tweets and links do not represent endorsement, approval or support. Image source: OpenClipArt.org, public domain.&lt;br /&gt;&lt;br /&gt;&lt;a href="http://twitter.com/Allergy"&gt;Follow me&lt;/a&gt; on Twitter:&lt;br /&gt;&lt;br /&gt;&lt;script type="text/javascript" language="JavaScript" src="http://twittercounter.com/embed/?username=Allergy&amp;amp;style=bird"&gt;&lt;/script&gt;&lt;span style="font-weight: bold;"&gt;&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;p&gt;   &lt;/p&gt;

Posted at &lt;a href="http://allergynotes.blogspot.com/"&gt;Allergy Notes&lt;/a&gt;. Stay updated and &lt;a href="http://feeds.feedburner.com/AllergyNotes"&gt;subscribe&lt;/a&gt;, or follow me on &lt;a href="http://twitter.com/Allergy"&gt;Twitter&lt;/a&gt;.&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2057269305378114997-382515139962205147?l=allergynotes.blogspot.com' alt='' /&gt;&lt;/div&gt;
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/mfGSCsrLazKXKRlIikImvWflNFo/0/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/mfGSCsrLazKXKRlIikImvWflNFo/0/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;br/&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/mfGSCsrLazKXKRlIikImvWflNFo/1/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/mfGSCsrLazKXKRlIikImvWflNFo/1/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/AllergyNotes/~4/WdbUXfkZCM0" height="1" width="1"/&gt;</content><link rel="replies" type="application/atom+xml" href="http://allergynotes.blogspot.com/feeds/382515139962205147/comments/default" title="Post Comments" /><link rel="replies" type="text/html" href="http://allergynotes.blogspot.com/2009/12/allergy-and-immunology-news-of-day_04.html#comment-form" title="0 Comments" /><link rel="edit" type="application/atom+xml" href="http://www.blogger.com/feeds/2057269305378114997/posts/default/382515139962205147?v=2" /><link rel="self" type="application/atom+xml" href="http://www.blogger.com/feeds/2057269305378114997/posts/default/382515139962205147?v=2" /><link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/AllergyNotes/~3/WdbUXfkZCM0/allergy-and-immunology-news-of-day_04.html" title="Allergy and Immunology News of the Day" /><author><name>Ves Dimov, M.D.</name><email>noreply@blogger.com</email><gd:extendedProperty name="OpenSocialUserId" value="07511862151701001787" /></author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="http://3.bp.blogspot.com/_LY7APi0bufs/SXFDHrotv1I/AAAAAAAADTg/Jq_g36NjLeg/s72-c/Clock-2-small.jpg" height="72" width="72" /><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total><feedburner:origLink>http://allergynotes.blogspot.com/2009/12/allergy-and-immunology-news-of-day_04.html</feedburner:origLink></entry><entry gd:etag="W/&quot;AkMEQXw4eip7ImA9WxNaGUw.&quot;"><id>tag:blogger.com,1999:blog-2057269305378114997.post-5259119848407845461</id><published>2009-12-04T04:20:00.004-05:00</published><updated>2009-12-04T04:20:00.232-05:00</updated><app:edited xmlns:app="http://www.w3.org/2007/app">2009-12-04T04:20:00.232-05:00</app:edited><category scheme="http://www.blogger.com/atom/ns#" term="Anaphylaxis" /><category scheme="http://www.blogger.com/atom/ns#" term="Medications" /><category scheme="http://www.blogger.com/atom/ns#" term="Drug Allergy" /><title>Omalizumab-associated anaphylactic reactions</title><content type="html">&lt;a href="http://2.bp.blogspot.com/_otrvz2aDOLk/R1F3Uc_hYjI/AAAAAAAAAB8/0JqWKUDnQB0/s1600-R/Xolair.jpg"&gt;&lt;img id="BLOGGER_PHOTO_ID_5139019843070157362" style="margin: 0px 0px 10px 10px; float: right;" alt="" src="http://2.bp.blogspot.com/_otrvz2aDOLk/R1F3Uc_hYjI/AAAAAAAAAB8/9kevOmxuS-c/s200/Xolair.jpg" border="0" /&gt;&lt;/a&gt;&lt;div&gt;The FDA reports for 2007-2008 were queried for new adverse reactions suspected to be due to omalizumab. &lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;There were 85 cases with an anaphylaxis descriptor and additional 33 cases consistent with anaphylaxis (118 total).&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;32 reactions occurred after the first dose and 14 were after the second dose of omalizumab.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;19 reactions occurred within 1 hour of omalizumab injection. &lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;You can read our case description here: &lt;a href="http://allergycases.org/2008/01/anaphylactic-reaction-to-omalizumab.html"&gt;Anaphylactic Reaction to Omalizumab (Xolair) in a Patient with Severe Asthma&lt;/a&gt;.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;References:&lt;/div&gt;&lt;div&gt;&lt;a href="http://www.ncbi.nlm.nih.gov/pubmed/19927545?dopt=Abstract"&gt;Omalizumab-associated anaphylactic reactions reported between January 2007 and June 2008&lt;/a&gt;. Lin RY, Rodriguez-Baez G, Bhargave GA. Ann Allergy Asthma Immunol. 2009 Nov;103(5):442-5.&lt;br /&gt;&lt;/div&gt;&lt;div&gt;Image source: &lt;a href="http://en.wikipedia.org/wiki/Image:Xolair.jpg"&gt;Wikipedia&lt;/a&gt;, public domain.&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;p&gt;   &lt;/p&gt;

Posted at &lt;a href="http://allergynotes.blogspot.com/"&gt;Allergy Notes&lt;/a&gt;. Stay updated and &lt;a href="http://feeds.feedburner.com/AllergyNotes"&gt;subscribe&lt;/a&gt;, or follow me on &lt;a href="http://twitter.com/Allergy"&gt;Twitter&lt;/a&gt;.&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2057269305378114997-5259119848407845461?l=allergynotes.blogspot.com' alt='' /&gt;&lt;/div&gt;
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/CtfVTIwD8J139LK1OgxKQK0zLoE/0/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/CtfVTIwD8J139LK1OgxKQK0zLoE/0/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;br/&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/CtfVTIwD8J139LK1OgxKQK0zLoE/1/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/CtfVTIwD8J139LK1OgxKQK0zLoE/1/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/AllergyNotes/~4/xQiVtJMmvXg" height="1" width="1"/&gt;</content><link rel="replies" type="application/atom+xml" href="http://allergynotes.blogspot.com/feeds/5259119848407845461/comments/default" title="Post Comments" /><link rel="replies" type="text/html" href="http://allergynotes.blogspot.com/2009/12/omalizumab-associated-anaphylactic.html#comment-form" title="0 Comments" /><link rel="edit" type="application/atom+xml" href="http://www.blogger.com/feeds/2057269305378114997/posts/default/5259119848407845461?v=2" /><link rel="self" type="application/atom+xml" href="http://www.blogger.com/feeds/2057269305378114997/posts/default/5259119848407845461?v=2" /><link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/AllergyNotes/~3/xQiVtJMmvXg/omalizumab-associated-anaphylactic.html" title="Omalizumab-associated anaphylactic reactions" /><author><name>Ves Dimov, M.D.</name><email>noreply@blogger.com</email><gd:extendedProperty name="OpenSocialUserId" value="07511862151701001787" /></author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="http://2.bp.blogspot.com/_otrvz2aDOLk/R1F3Uc_hYjI/AAAAAAAAAB8/9kevOmxuS-c/s72-c/Xolair.jpg" height="72" width="72" /><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total><feedburner:origLink>http://allergynotes.blogspot.com/2009/12/omalizumab-associated-anaphylactic.html</feedburner:origLink></entry><entry gd:etag="W/&quot;CU4CQXYyeCp7ImA9WxNaGEg.&quot;"><id>tag:blogger.com,1999:blog-2057269305378114997.post-8477009305797558139</id><published>2009-12-03T10:26:00.002-05:00</published><updated>2009-12-03T10:26:00.890-05:00</updated><app:edited xmlns:app="http://www.w3.org/2007/app">2009-12-03T10:26:00.890-05:00</app:edited><category scheme="http://www.blogger.com/atom/ns#" term="News of the Day" /><title>Allergy and Immunology News of the Day</title><content type="html">&lt;a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="http://3.bp.blogspot.com/_LY7APi0bufs/SXFDHrotv1I/AAAAAAAADTg/Jq_g36NjLeg/s1600-h/Clock-2-small.jpg"&gt;&lt;img style="margin: 0pt 0pt 10px 10px; float: right; cursor: pointer; width: 100px; height: 100px;" src="http://3.bp.blogspot.com/_LY7APi0bufs/SXFDHrotv1I/AAAAAAAADTg/Jq_g36NjLeg/s200/Clock-2-small.jpg" alt="" id="BLOGGER_PHOTO_ID_5292084836388683602" border="0"&gt;&lt;/a&gt; &lt;a href="http://casesblog.blogspot.com/search/label/Health%20News%20of%20the%20Day"&gt;Health News of the Day&lt;/a&gt; is a daily summary made from the &lt;a href="https://twitter.com/Allergy"&gt;selected links I post on Twitter&lt;/a&gt;. It is in a bullet points format with links to the original sources which include 350 RSS feeds that produce about 2,500 items per day.&lt;font class="status-body"&gt;&lt;font class="entry-content"&gt;&lt;br /&gt;&lt;br /&gt;&lt;/font&gt;&lt;/font&gt;&lt;font class="status-body"&gt;&lt;font class="entry-content"&gt;&lt;/font&gt;&lt;/font&gt;&lt;blockquote&gt;&lt;font class="status-body"&gt;&lt;font class="entry-content"&gt;Negative predictive value of PCN provocation isn't 100% but none of false negatives  had a life-threatening reaction &lt;a href="http://bit.ly/3xVAvD" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/3xVAvD&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;/font&gt;&lt;/font&gt;&lt;font class="status-body"&gt;&lt;font class="entry-content"&gt;Should common variable immunedeficiency (CVID) patients receive chemoprophylaxis for influenza? &lt;a href="http://bit.ly/4coHdD" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/4coHdD&lt;/a&gt; - No good evidence.&lt;br /&gt;&lt;br /&gt;&lt;/font&gt;&lt;/font&gt;&lt;font class="status-body"&gt;&lt;font class="entry-content"&gt;High sensitization rate to food allergens in breastfed infants with atopic dermatitis. &lt;a href="http://bit.ly/VYCNf" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/VYCNf&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;/font&gt;&lt;/font&gt;&lt;font class="status-body"&gt;&lt;font class="entry-content"&gt;Differences in physicians' knowledge and attitudes toward the black box warning on long-acting beta-agonists &lt;a href="http://bit.ly/hbpLU" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/hbpLU&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;/font&gt;&lt;/font&gt;&lt;font class="status-body"&gt;&lt;font class="entry-content"&gt;Improved sleep after treatment of allergic rhinitis. &lt;a href="http://bit.ly/2eDBVW" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/2eDBVW&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;/font&gt;&lt;/font&gt;&lt;font class="status-body"&gt;&lt;font class="entry-content"&gt;Atopic march is a useful paradigm to describe the clinically observed progression of atopy in certain children. &lt;a href="http://bit.ly/8Vkub" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/8Vkub&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;/font&gt;&lt;/font&gt;&lt;font class="status-body"&gt;&lt;font class="entry-content"&gt;Smoking cessation toolbox for allergists - tobacco use treatment 5 A's (ask, advise, assess, assist, and arrange) &lt;a href="http://bit.ly/XX2KP" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/XX2KP&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;/font&gt;&lt;/font&gt;&lt;font class="status-body"&gt;&lt;font class="entry-content"&gt;Homozygous mutations in the CARD9 gene are associated with chronic mucocutaneous candidiasis. &lt;/font&gt;&lt;/font&gt;&lt;font class="status-body"&gt;&lt;font class="entry-content"&gt;Dysfunction of CARD9 impairs the innate signaling of dectin-1, an antifungal pattern-recognition receptor &lt;a href="http://bit.ly/2JilD5" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/2JilD5&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;/font&gt;&lt;/font&gt;&lt;font class="status-body"&gt;&lt;font class="entry-content"&gt;Cold-Induced Urticaria: Positive ice-cube test &amp;amp; early hive marking edge up cup filled with ice &lt;a href="http://twitpic.com/nikxz" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://twitpic.com/nikxz&lt;/a&gt; via @&lt;a class="tweet-url username" href="http://twitter.com/MatthewBowdish"&gt;MatthewBowdish&lt;/a&gt;&lt;/font&gt;&lt;/font&gt;&lt;br /&gt;&lt;font class="status-body"&gt;&lt;font class="entry-content"&gt;&lt;br /&gt;&lt;/font&gt;&lt;/font&gt;&lt;font class="status-body"&gt;&lt;font class="entry-content"&gt;Allergy 2.0: Medical Web 2.0 Guidance Package &lt;a href="http://bit.ly/4DouhA" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/4DouhA&lt;/a&gt;&lt;/font&gt;&lt;/font&gt;&lt;br /&gt;&lt;font class="status-body"&gt;&lt;font class="entry-content"&gt;&lt;br /&gt;&lt;/font&gt;&lt;/font&gt;&lt;/blockquote&gt;Medical news tweets are not research articles - they are 140-character messages - please always go to the original source, links, etc. Tweets and links do not represent endorsement, approval or support. Image source: OpenClipArt.org, public domain.&lt;br /&gt;&lt;br /&gt;&lt;a href="http://twitter.com/Allergy"&gt;Follow me&lt;/a&gt; on Twitter:&lt;br /&gt;&lt;br /&gt;&lt;script type="text/javascript" language="JavaScript" src="http://twittercounter.com/embed/?username=Allergy&amp;amp;style=bird"&gt;&lt;/script&gt;&lt;font style="font-weight: bold;"&gt;&lt;/font&gt;&lt;div class="blogger-post-footer"&gt;&lt;p&gt;   &lt;/p&gt;

Posted at &lt;a href="http://allergynotes.blogspot.com/"&gt;Allergy Notes&lt;/a&gt;. Stay updated and &lt;a href="http://feeds.feedburner.com/AllergyNotes"&gt;subscribe&lt;/a&gt;, or follow me on &lt;a href="http://twitter.com/Allergy"&gt;Twitter&lt;/a&gt;.&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2057269305378114997-8477009305797558139?l=allergynotes.blogspot.com' alt='' /&gt;&lt;/div&gt;
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/CNMM01G6HrwSrqdLFbDdCwzK5Oc/0/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/CNMM01G6HrwSrqdLFbDdCwzK5Oc/0/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;br/&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/CNMM01G6HrwSrqdLFbDdCwzK5Oc/1/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/CNMM01G6HrwSrqdLFbDdCwzK5Oc/1/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/AllergyNotes/~4/PNy6d1qDgpU" height="1" width="1"/&gt;</content><link rel="replies" type="application/atom+xml" href="http://allergynotes.blogspot.com/feeds/8477009305797558139/comments/default" title="Post Comments" /><link rel="replies" type="text/html" href="http://allergynotes.blogspot.com/2009/12/allergy-and-immunology-news-of-day_03.html#comment-form" title="0 Comments" /><link rel="edit" type="application/atom+xml" href="http://www.blogger.com/feeds/2057269305378114997/posts/default/8477009305797558139?v=2" /><link rel="self" type="application/atom+xml" href="http://www.blogger.com/feeds/2057269305378114997/posts/default/8477009305797558139?v=2" /><link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/AllergyNotes/~3/PNy6d1qDgpU/allergy-and-immunology-news-of-day_03.html" title="Allergy and Immunology News of the Day" /><author><name>Ves Dimov, M.D.</name><email>noreply@blogger.com</email><gd:extendedProperty name="OpenSocialUserId" value="07511862151701001787" /></author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="http://3.bp.blogspot.com/_LY7APi0bufs/SXFDHrotv1I/AAAAAAAADTg/Jq_g36NjLeg/s72-c/Clock-2-small.jpg" height="72" width="72" /><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total><feedburner:origLink>http://allergynotes.blogspot.com/2009/12/allergy-and-immunology-news-of-day_03.html</feedburner:origLink></entry><entry gd:etag="W/&quot;A0QGQXg-fSp7ImA9WxNaGE4.&quot;"><id>tag:blogger.com,1999:blog-2057269305378114997.post-491832836231835910</id><published>2009-12-03T06:22:00.000-05:00</published><updated>2009-12-03T06:22:00.655-05:00</updated><app:edited xmlns:app="http://www.w3.org/2007/app">2009-12-03T06:22:00.655-05:00</app:edited><category scheme="http://www.blogger.com/atom/ns#" term="Rhinitis" /><category scheme="http://www.blogger.com/atom/ns#" term="Medications" /><title>Intranasal antihistamines as first-line treatment of allergic rhinitis</title><content type="html">&lt;div&gt;&lt;a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="http://2.bp.blogspot.com/_LY7APi0bufs/RnEy1ofMZiI/AAAAAAAABZA/tjt9NsD_7es/s1600-h/Nose.jpg"&gt;&lt;img src="http://2.bp.blogspot.com/_LY7APi0bufs/RnEy1ofMZiI/AAAAAAAABZA/tjt9NsD_7es/s200/Nose.jpg" alt="" id="BLOGGER_PHOTO_ID_5075894152005969442" align="right" border="0" /&gt;&lt;/a&gt;Azelastine nasal spray, 0.1%, and olopatadine nasal spray, 0.6%, have rapid onsets of action, are well tolerated, and have clinical efficacy for treating allergic rhinitis that is equal or superior to oral second-generation antihistamines. &lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;Both have a significant effect on nasal congestion. Azelastine is also approved for nonallergic rhinitis.&lt;br /&gt;&lt;br /&gt;&lt;a href="http://4.bp.blogspot.com/_-Uzu0xg5lh0/SK0DnBuExXI/AAAAAAAAAO8/oShYJcgDTM0/s1600-h/Treatment_of_Allergic_Rhinitis.jpg"&gt;&lt;img id="BLOGGER_PHOTO_ID_5236845910713222514" style="cursor: pointer;" alt="" src="http://4.bp.blogspot.com/_-Uzu0xg5lh0/SK0DnBuExXI/AAAAAAAAAO8/oShYJcgDTM0/s200/Treatment_of_Allergic_Rhinitis.jpg" border="0" /&gt;&lt;/a&gt;&lt;br /&gt;Medications for Allergic Rhinitis (click to enlarge the image).&lt;br /&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;Older data suggest that intranasal steroids have greater efficacy than nasal antihistamines but more recent comparisons in mild to moderate allergic rhinitis have shown equal or noninferior efficacy. &lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;In addition, the combination of a nasal antihistamine and intranasal steroid may provide additive benefits in more severe rhinitis. Premixed antihistamine-steroid combinations may offer additional benefits in the treatment of mixed (AR/non-AR) rhinitis.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="http://upload.wikimedia.org/wikipedia/commons/thumb/3/3c/Azelastine.svg/220px-Azelastine.svg.png"&gt;&lt;img style="cursor: pointer; width: 220px; height: 255px;" src="http://upload.wikimedia.org/wikipedia/commons/thumb/3/3c/Azelastine.svg/220px-Azelastine.svg.png" alt="" border="0" /&gt;&lt;/a&gt;&lt;br /&gt;Azelastine. Image source: &lt;a href="http://en.wikipedia.org/wiki/Azelastine"&gt;Wikipedia&lt;/a&gt;, public domain.&lt;br /&gt;&lt;br /&gt;&lt;a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="http://upload.wikimedia.org/wikipedia/commons/thumb/e/e5/Olopatadine.svg/220px-Olopatadine.svg.png"&gt;&lt;img style="cursor: pointer; width: 220px; height: 172px;" src="http://upload.wikimedia.org/wikipedia/commons/thumb/e/e5/Olopatadine.svg/220px-Olopatadine.svg.png" alt="" border="0" /&gt;&lt;/a&gt;&lt;br /&gt;Olopatadine. Image source: &lt;a href="http://en.wikipedia.org/wiki/Olopatadine"&gt;Wikipedia&lt;/a&gt;, public domain.&lt;br /&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;This literature review supports current recommendations for nasal antihistamines as first-line therapy for allergic rhinitis. &lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;References:&lt;div&gt;&lt;a href="http://www.ncbi.nlm.nih.gov/pubmed/19927534?dopt=Abstract"&gt;Azelastine and olopatadine in the treatment of allergic rhinitis&lt;/a&gt;. Kaliner MA. Ann Allergy Asthma Immunol. 2009 Nov;103(5):373-80.&lt;br /&gt;&lt;a title="Seasonal Allergic Rhinitis: A Short Review" href="http://allergycases.org/2005/02/short-review-seasonal-allergic-rhinitis.html" id="wb5j"&gt;Allergic Rhinitis: A Short Review&lt;/a&gt;&lt;br /&gt;&lt;a href="http://allergycases.org/2006/01/mind-maps-allergic-rhinitis.html"&gt;Mind Maps: Allergic Rhinitis&lt;/a&gt;&lt;br /&gt;&lt;a href="http://allergycases.org/2007/01/mnemonics-allergic-rhinitis.html"&gt;Mnemonics: Allergic Rhinitis&lt;/a&gt;&lt;br /&gt;Image source: Wikipedia, a &lt;a href="http://en.wikipedia.org/wiki/Image:Neus1.jpg"&gt;Creative Commons license&lt;/a&gt;.&lt;br /&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;p&gt;   &lt;/p&gt;

Posted at &lt;a href="http://allergynotes.blogspot.com/"&gt;Allergy Notes&lt;/a&gt;. Stay updated and &lt;a href="http://feeds.feedburner.com/AllergyNotes"&gt;subscribe&lt;/a&gt;, or follow me on &lt;a href="http://twitter.com/Allergy"&gt;Twitter&lt;/a&gt;.&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2057269305378114997-491832836231835910?l=allergynotes.blogspot.com' alt='' /&gt;&lt;/div&gt;
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/nFo_k5_O0Y6VbWMmA8C3DSnM1gg/0/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/nFo_k5_O0Y6VbWMmA8C3DSnM1gg/0/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;br/&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/nFo_k5_O0Y6VbWMmA8C3DSnM1gg/1/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/nFo_k5_O0Y6VbWMmA8C3DSnM1gg/1/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/AllergyNotes/~4/rI7PgWojphM" height="1" width="1"/&gt;</content><link rel="replies" type="application/atom+xml" href="http://allergynotes.blogspot.com/feeds/491832836231835910/comments/default" title="Post Comments" /><link rel="replies" type="text/html" href="http://allergynotes.blogspot.com/2009/12/intranasal-antihistamines-as-first-line.html#comment-form" title="0 Comments" /><link rel="edit" type="application/atom+xml" href="http://www.blogger.com/feeds/2057269305378114997/posts/default/491832836231835910?v=2" /><link rel="self" type="application/atom+xml" href="http://www.blogger.com/feeds/2057269305378114997/posts/default/491832836231835910?v=2" /><link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/AllergyNotes/~3/rI7PgWojphM/intranasal-antihistamines-as-first-line.html" title="Intranasal antihistamines as first-line treatment of allergic rhinitis" /><author><name>Ves Dimov, M.D.</name><email>noreply@blogger.com</email><gd:extendedProperty name="OpenSocialUserId" value="07511862151701001787" /></author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="http://2.bp.blogspot.com/_LY7APi0bufs/RnEy1ofMZiI/AAAAAAAABZA/tjt9NsD_7es/s72-c/Nose.jpg" height="72" width="72" /><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total><feedburner:origLink>http://allergynotes.blogspot.com/2009/12/intranasal-antihistamines-as-first-line.html</feedburner:origLink></entry><entry gd:etag="W/&quot;CUIMQX8_cSp7ImA9WxNaF0o.&quot;"><id>tag:blogger.com,1999:blog-2057269305378114997.post-7152434260425562063</id><published>2009-12-02T11:50:00.003-05:00</published><updated>2009-12-02T12:06:20.149-05:00</updated><app:edited xmlns:app="http://www.w3.org/2007/app">2009-12-02T12:06:20.149-05:00</app:edited><category scheme="http://www.blogger.com/atom/ns#" term="Angioedema" /><title>Subcutaneous kallikrein inhibitor ecallantide (Kalbitor) approved for treatment of hereditary angioedema (HAE)</title><content type="html">&lt;div&gt;&lt;b&gt;What is HAE?&lt;/b&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;Between 8,000 and 10,000 people in the U.S. are affected by the most common form of HAE which is caused by an autosomal dominant mutation that decreases C1 inhibitor levels.&lt;br /&gt;&lt;br /&gt;Plasma kallikrein plays a major role in the kallikrein-kinin cascade producing bradykinin. Bradykinin is a vasodilator, which increases vascular permeability, activates inflammation and produces pain.&lt;br /&gt;&lt;br /&gt;&lt;div&gt;&lt;b&gt;Ecallantide (DX-88, Kalbitor)&lt;/b&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;span&gt;&lt;span&gt;Ecallantide (DX-88, Kalbitor) is a subcutaneous kallikrein inhibitor which was approved for treatment of hereditary angioedema (HAE)  in patients 16 years of age and older on December 2, 2009.&lt;br /&gt;&lt;br /&gt;&lt;a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="http://2.bp.blogspot.com/_-Uzu0xg5lh0/R5a2BDkhs1I/AAAAAAAAAH0/z-gBaRg_wuQ/s1600-h/New_therapies_for_hereditary_angioedema_%28HAE%29.jpg"&gt;&lt;img style="cursor: pointer;" src="http://2.bp.blogspot.com/_-Uzu0xg5lh0/R5a2BDkhs1I/AAAAAAAAAH0/z-gBaRg_wuQ/s200/New_therapies_for_hereditary_angioedema_%28HAE%29.jpg" alt="" id="BLOGGER_PHOTO_ID_5158510552454116178" border="0" /&gt;&lt;/a&gt;&lt;br /&gt;New therapies for hereditary angioedema (HAE) (click to enlarge the image).&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;The drug is to be launched in the first quarter of 2010 and see an ex-U.S. partnership in the first half of next year. Kalbitor is the only approved treatment for life-threatening laryngeal attacks.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;&lt;div&gt;The drug's short half-life is the main reason for its suitability as a treatment for acute attacks only and not as a preventive therapy.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;Kalbitor has a half-life of about two hours, while Cinryze has a half-life of about 56 hours and Berinert has about 22 hours.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;&lt;b&gt;Black-box warning &lt;/b&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;&lt;div&gt;The labelling of the drug includes a black-box warning for possible allergic reactions which usually occur within 10 minutes of the injection. This means that the injections will typically be administered in a supervised setting (doctor's office) rather than by the patient at home.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;As a condition of the FDA approval, Dyax is required to set up a risk management program to warn patients that Kalbitor can cause severe allergic reactions.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;&lt;div&gt;&lt;b&gt;Other treatments of HAE&lt;/b&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;&lt;div&gt;Cinryze is only approved as a preventive therapy.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;Berinert was approved by the FDA in October 2009 for only acute abdominal and facial attacks of the disease.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;References:&lt;/div&gt;&lt;div&gt;&lt;a href="http://www.reuters.com/article/companyNews/idUSBNG42215220091202"&gt;Dyax shrs soar after FDA approves genetic-disorder drug&lt;/a&gt;. Reuters.&lt;/div&gt;&lt;div&gt;&lt;a href="http://allergynotes.blogspot.com/2009/11/subcutaneous-kallikrein-inhibitor.html"&gt;Subcutaneous kallikrein inhibitor ecallantide as a treatment for hereditary angioedema (HAE)&lt;/a&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;a href="http://www.thestreet.com/_yahoo/story/10636438/1/fda-approves-two-new-drugs-biobuzz.html?cm_ven=YAHOO&amp;amp;cm_cat=FREE&amp;amp;cm_ite=NA"&gt;FDA Approves Two New Drugs: BioBuzz&lt;/a&gt;. TheStreet.com.&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;p&gt;   &lt;/p&gt;

Posted at &lt;a href="http://allergynotes.blogspot.com/"&gt;Allergy Notes&lt;/a&gt;. Stay updated and &lt;a href="http://feeds.feedburner.com/AllergyNotes"&gt;subscribe&lt;/a&gt;, or follow me on &lt;a href="http://twitter.com/Allergy"&gt;Twitter&lt;/a&gt;.&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2057269305378114997-7152434260425562063?l=allergynotes.blogspot.com' alt='' /&gt;&lt;/div&gt;
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/qOTaXFbZSloyVXB2b6M3Rkc-zYY/0/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/qOTaXFbZSloyVXB2b6M3Rkc-zYY/0/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;br/&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/qOTaXFbZSloyVXB2b6M3Rkc-zYY/1/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/qOTaXFbZSloyVXB2b6M3Rkc-zYY/1/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/AllergyNotes/~4/3O-4k_AqTV4" height="1" width="1"/&gt;</content><link rel="replies" type="application/atom+xml" href="http://allergynotes.blogspot.com/feeds/7152434260425562063/comments/default" title="Post Comments" /><link rel="replies" type="text/html" href="http://allergynotes.blogspot.com/2009/12/subcutaneous-kallikrein-inhibitor.html#comment-form" title="0 Comments" /><link rel="edit" type="application/atom+xml" href="http://www.blogger.com/feeds/2057269305378114997/posts/default/7152434260425562063?v=2" /><link rel="self" type="application/atom+xml" href="http://www.blogger.com/feeds/2057269305378114997/posts/default/7152434260425562063?v=2" /><link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/AllergyNotes/~3/3O-4k_AqTV4/subcutaneous-kallikrein-inhibitor.html" title="Subcutaneous kallikrein inhibitor ecallantide (Kalbitor) approved for treatment of hereditary angioedema (HAE)" /><author><name>Ves Dimov, M.D.</name><email>noreply@blogger.com</email><gd:extendedProperty name="OpenSocialUserId" value="07511862151701001787" /></author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="http://2.bp.blogspot.com/_-Uzu0xg5lh0/R5a2BDkhs1I/AAAAAAAAAH0/z-gBaRg_wuQ/s72-c/New_therapies_for_hereditary_angioedema_%28HAE%29.jpg" height="72" width="72" /><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total><feedburner:origLink>http://allergynotes.blogspot.com/2009/12/subcutaneous-kallikrein-inhibitor.html</feedburner:origLink></entry><entry gd:etag="W/&quot;DUQGQX4-cSp7ImA9WxNaF0s.&quot;"><id>tag:blogger.com,1999:blog-2057269305378114997.post-6994898077459856350</id><published>2009-12-02T10:22:00.002-05:00</published><updated>2009-12-02T10:22:00.059-05:00</updated><app:edited xmlns:app="http://www.w3.org/2007/app">2009-12-02T10:22:00.059-05:00</app:edited><category scheme="http://www.blogger.com/atom/ns#" term="News of the Day" /><title>Allergy and Immunology News of the Day</title><content type="html">&lt;a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="http://3.bp.blogspot.com/_LY7APi0bufs/SXFDHrotv1I/AAAAAAAADTg/Jq_g36NjLeg/s1600-h/Clock-2-small.jpg"&gt;&lt;img style="margin: 0pt 0pt 10px 10px; float: right; cursor: pointer; width: 100px; height: 100px;" src="http://3.bp.blogspot.com/_LY7APi0bufs/SXFDHrotv1I/AAAAAAAADTg/Jq_g36NjLeg/s200/Clock-2-small.jpg" alt="" id="BLOGGER_PHOTO_ID_5292084836388683602" border="0" /&gt;&lt;/a&gt; &lt;a href="http://casesblog.blogspot.com/search/label/Health%20News%20of%20the%20Day"&gt;Health News of the Day&lt;/a&gt; is a daily summary made from the &lt;a href="https://twitter.com/Allergy"&gt;selected links I post on Twitter&lt;/a&gt;. It is in a bullet points format with links to the original sources which include 350 RSS feeds that produce about 2,500 items per day.&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;&lt;/span&gt;&lt;/span&gt;&lt;blockquote&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;People with difficult-to-control asthma are often not taking their anti-asthma medication as prescribed by their doctor. &lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;Even when prescribed high doses of inhaled steroids, 5% of adults with asthma remain difficult to control. &lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;Women were most apt to be lax in taking their asthma controller medication as prescribed. &lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;Among 51 asthma patients who were supposed to be using oral steroids, blood tests showed that 45% were nonadherent &lt;a href="http://bit.ly/2Ak9ce" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/2Ak9ce&lt;/a&gt;&lt;/span&gt;&lt;/span&gt; -- &lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;Difficult asthma may be due to difficult patients &lt;a href="http://is.gd/4zFka" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://is.gd/4zFka&lt;/a&gt;&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;Recombinant Major Cat Allergen, Fel d 1,  becomes available for immunological investigations, diagnosis and treatment &lt;a href="http://bit.ly/v0eac" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/v0eac&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;New antihistamine bilastine 20 mg as effective as levocetirizine 5 mg for treatment of chronic idiopathic urticaria &lt;a href="http://bit.ly/4bt89z" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/4bt89z&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;The Longest Wheal Diameter Is the Optimal Measurement for the Evaluation of Skin Prick Tests &lt;a href="http://bit.ly/3SETBH" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/3SETBH&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;Allergy Treatment Pyramid &lt;a href="http://bit.ly/AbFMQ" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/AbFMQ&lt;/a&gt;&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;Anaphylaxis action plans &lt;a href="http://bit.ly/3SBXWm" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/3SBXWm&lt;/a&gt; and Food Allergy Action Plan &lt;a href="http://bit.ly/5KryG" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/5KryG&lt;/a&gt;&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;If you have asthma, be sure to get the injectable influenza vaccines, not the vaccine nasal spray - AAAAI &lt;a href="http://bit.ly/4rQEEQ" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/4rQEEQ&lt;/a&gt; -- &lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;Live attenuated influenza vaccine (nasal spray) not recommended for patients with asthma - it can trigger exacerbation &lt;a href="http://bit.ly/4rQEEQ" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/4rQEEQ&lt;/a&gt;&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;Sample online appointment form: &lt;a href="http://bit.ly/3WcuiK" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/3WcuiK&lt;/a&gt;&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;/blockquote&gt;Medical news tweets are not research articles - they are 140-character messages - please always go to the original source, links, etc. Tweets and links do not represent endorsement, approval or support. Image source: OpenClipArt.org, public domain.&lt;br /&gt;&lt;br /&gt;&lt;a href="http://twitter.com/Allergy"&gt;Follow me&lt;/a&gt; on Twitter:&lt;br /&gt;&lt;br /&gt;&lt;script type="text/javascript" language="JavaScript" src="http://twittercounter.com/embed/?username=Allergy&amp;amp;style=bird"&gt;&lt;/script&gt;&lt;span style="font-weight: bold;"&gt;&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;p&gt;   &lt;/p&gt;

Posted at &lt;a href="http://allergynotes.blogspot.com/"&gt;Allergy Notes&lt;/a&gt;. Stay updated and &lt;a href="http://feeds.feedburner.com/AllergyNotes"&gt;subscribe&lt;/a&gt;, or follow me on &lt;a href="http://twitter.com/Allergy"&gt;Twitter&lt;/a&gt;.&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2057269305378114997-6994898077459856350?l=allergynotes.blogspot.com' alt='' /&gt;&lt;/div&gt;
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/VzOiX_MQNXf5kl7dV1T1ENCXikw/0/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/VzOiX_MQNXf5kl7dV1T1ENCXikw/0/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;br/&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/VzOiX_MQNXf5kl7dV1T1ENCXikw/1/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/VzOiX_MQNXf5kl7dV1T1ENCXikw/1/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/AllergyNotes/~4/dohcED8R0SM" height="1" width="1"/&gt;</content><link rel="replies" type="application/atom+xml" href="http://allergynotes.blogspot.com/feeds/6994898077459856350/comments/default" title="Post Comments" /><link rel="replies" type="text/html" href="http://allergynotes.blogspot.com/2009/12/allergy-and-immunology-news-of-day_02.html#comment-form" title="0 Comments" /><link rel="edit" type="application/atom+xml" href="http://www.blogger.com/feeds/2057269305378114997/posts/default/6994898077459856350?v=2" /><link rel="self" type="application/atom+xml" href="http://www.blogger.com/feeds/2057269305378114997/posts/default/6994898077459856350?v=2" /><link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/AllergyNotes/~3/dohcED8R0SM/allergy-and-immunology-news-of-day_02.html" title="Allergy and Immunology News of the Day" /><author><name>Ves Dimov, M.D.</name><email>noreply@blogger.com</email><gd:extendedProperty name="OpenSocialUserId" value="07511862151701001787" /></author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="http://3.bp.blogspot.com/_LY7APi0bufs/SXFDHrotv1I/AAAAAAAADTg/Jq_g36NjLeg/s72-c/Clock-2-small.jpg" height="72" width="72" /><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total><feedburner:origLink>http://allergynotes.blogspot.com/2009/12/allergy-and-immunology-news-of-day_02.html</feedburner:origLink></entry><entry gd:etag="W/&quot;Ak4CQXs_fSp7ImA9WxNaF0k.&quot;"><id>tag:blogger.com,1999:blog-2057269305378114997.post-1712311321788474200</id><published>2009-12-02T05:16:00.000-05:00</published><updated>2009-12-02T05:16:00.545-05:00</updated><app:edited xmlns:app="http://www.w3.org/2007/app">2009-12-02T05:16:00.545-05:00</app:edited><category scheme="http://www.blogger.com/atom/ns#" term="Eosinophilic esophagitis" /><title>Dysphagia and anorexia/early satiety may distinguish eosinophilic esophagitis from GERD</title><content type="html">&lt;a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="http://2.bp.blogspot.com/_LY7APi0bufs/Rk6GLI7JuVI/AAAAAAAABRc/umf_uf2r6MA/s1600-h/Multi_ring_esophagus.jpg"&gt;&lt;img style="cursor: pointer;" src="http://2.bp.blogspot.com/_LY7APi0bufs/Rk6GLI7JuVI/AAAAAAAABRc/umf_uf2r6MA/s200/Multi_ring_esophagus.jpg" alt="" id="BLOGGER_PHOTO_ID_5066134156770654546" align="right" border="0" /&gt;&lt;/a&gt;Eosinophilic esophagitis (EE) is difficult to distinguish clinically from other causes of esophagitis, especially gastroesophageal reflux disease (GERD). &lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;A prospective study evaluated a symptom scoring tool in patients with EE and patients with GERD, allergic and nonallergic controls.&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;The total symptom score was higher among patients with EE and GERD. &lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;Only dysphagia and anorexia/early satiety in EE patients helped discriminate EE from GERD. These symptoms also correlated with the severity of histologic and endoscopic findings. &lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;The study authors concluded that dysphagia and anorexia/early satiety identify pediatric patients with EE and correlate symptoms with tissue inflammation. &lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt; References: &lt;/div&gt;&lt;div&gt;&lt;a href="http://www.ncbi.nlm.nih.gov/pubmed/19927538?dopt=Abstract"&gt;A symptom scoring tool for identifying pediatric patients with eosinophilic esophagitis and correlating symptoms with inflammation&lt;/a&gt;. Aceves SS, Newbury RO, Dohil MA, Bastian JF, Dohil R. Ann Allergy Asthma Immunol. 2009 Nov;103(5):401-6.&lt;/div&gt;&lt;div&gt;&lt;a href="http://allergycases.org/2008/05/eosinophilic-esophagitis.html"&gt;Eosinophilic Esophagitis: A Short Review&lt;/a&gt;&lt;br /&gt;&lt;a href="http://allergycases.org/2008/08/mind-maps-eosinophilic-esophagitis.html"&gt;Mind Maps: Eosinophilic Esophagitis&lt;/a&gt;&lt;br /&gt;&lt;a href="http://allergycases.org/2008/08/mnemonics-eosinophilic-esophagitis.html"&gt;Mnemonics: Eosinophilic Esophagitis&lt;/a&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;Image source: Eosinophilic esophagitis, &lt;a href="http://en.wikipedia.org/wiki/File:Multi_ring_esophagus.jpg"&gt;Wikipedia&lt;/a&gt;, GNU Free Documentation License.&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;p&gt;   &lt;/p&gt;

Posted at &lt;a href="http://allergynotes.blogspot.com/"&gt;Allergy Notes&lt;/a&gt;. Stay updated and &lt;a href="http://feeds.feedburner.com/AllergyNotes"&gt;subscribe&lt;/a&gt;, or follow me on &lt;a href="http://twitter.com/Allergy"&gt;Twitter&lt;/a&gt;.&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2057269305378114997-1712311321788474200?l=allergynotes.blogspot.com' alt='' /&gt;&lt;/div&gt;
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/BCac2bgHwLT78Oogsf8QPBvTIOk/0/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/BCac2bgHwLT78Oogsf8QPBvTIOk/0/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;br/&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/BCac2bgHwLT78Oogsf8QPBvTIOk/1/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/BCac2bgHwLT78Oogsf8QPBvTIOk/1/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/AllergyNotes/~4/sBqLbBgEWaA" height="1" width="1"/&gt;</content><link rel="replies" type="application/atom+xml" href="http://allergynotes.blogspot.com/feeds/1712311321788474200/comments/default" title="Post Comments" /><link rel="replies" type="text/html" href="http://allergynotes.blogspot.com/2009/12/dysphagia-and-anorexiaearly-satiety-may.html#comment-form" title="0 Comments" /><link rel="edit" type="application/atom+xml" href="http://www.blogger.com/feeds/2057269305378114997/posts/default/1712311321788474200?v=2" /><link rel="self" type="application/atom+xml" href="http://www.blogger.com/feeds/2057269305378114997/posts/default/1712311321788474200?v=2" /><link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/AllergyNotes/~3/sBqLbBgEWaA/dysphagia-and-anorexiaearly-satiety-may.html" title="Dysphagia and anorexia/early satiety may distinguish eosinophilic esophagitis from GERD" /><author><name>Ves Dimov, M.D.</name><email>noreply@blogger.com</email><gd:extendedProperty name="OpenSocialUserId" value="07511862151701001787" /></author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="http://2.bp.blogspot.com/_LY7APi0bufs/Rk6GLI7JuVI/AAAAAAAABRc/umf_uf2r6MA/s72-c/Multi_ring_esophagus.jpg" height="72" width="72" /><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total><feedburner:origLink>http://allergynotes.blogspot.com/2009/12/dysphagia-and-anorexiaearly-satiety-may.html</feedburner:origLink></entry><entry gd:etag="W/&quot;Ck8EQX8yfSp7ImA9WxNaFkU.&quot;"><id>tag:blogger.com,1999:blog-2057269305378114997.post-839296356832177006</id><published>2009-12-01T10:20:00.001-05:00</published><updated>2009-12-01T10:20:00.195-05:00</updated><app:edited xmlns:app="http://www.w3.org/2007/app">2009-12-01T10:20:00.195-05:00</app:edited><category scheme="http://www.blogger.com/atom/ns#" term="News of the Day" /><title>Allergy and Immunology News of the Day</title><content type="html">&lt;a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="http://3.bp.blogspot.com/_LY7APi0bufs/SXFDHrotv1I/AAAAAAAADTg/Jq_g36NjLeg/s1600-h/Clock-2-small.jpg"&gt;&lt;img style="margin: 0pt 0pt 10px 10px; float: right; cursor: pointer; width: 100px; height: 100px;" src="http://3.bp.blogspot.com/_LY7APi0bufs/SXFDHrotv1I/AAAAAAAADTg/Jq_g36NjLeg/s200/Clock-2-small.jpg" alt="" id="BLOGGER_PHOTO_ID_5292084836388683602" border="0" /&gt;&lt;/a&gt; &lt;a href="http://casesblog.blogspot.com/search/label/Health%20News%20of%20the%20Day"&gt;Health News of the Day&lt;/a&gt; is a daily summary made from the &lt;a href="https://twitter.com/Allergy"&gt;selected links I post on Twitter&lt;/a&gt;. It is in a bullet points format with links to the original sources which include 350 RSS feeds that produce about 2,500 items per day.&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;&lt;/span&gt;&lt;/span&gt;&lt;blockquote&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;Prophylactic antipyretics at the time of vaccination may reduce antibody responses to several vaccine antigens &lt;a href="http://bit.ly/BR3XR" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/BR3XR&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;FDA requests more information from Novartis prior to QAB149 (indacaterol) approval &lt;a href="http://bit.ly/3w6bpH" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/3w6bpH&lt;/a&gt; -- &lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;QAB149, indacaterol, the first once-daily LABA is already approved in Europe. Noavrtis to address FDA's dosing concerns &lt;a href="http://bit.ly/3w6bpH" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/3w6bpH&lt;/a&gt;&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;Omalizumab Highly Effective for Refractory Urticaria in Randomized Trial &lt;a href="http://bit.ly/2KCtEX" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/2KCtEX&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;ICS fluticasone decreases inflammation and FEV1 decline in COPD. Adding LABAs does not enhance these effects. &lt;a href="http://bit.ly/1uK7Q4" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/1uK7Q4&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;How does a tick bite trigger a sudden allergy to meat? WaPost &lt;a href="http://bit.ly/15CqtN" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/15CqtN&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;Belimumab (Benlysta) is a human monoclonal antibody that could become the first new drug for SLE in five decades &lt;a href="http://bit.ly/4CSdAq" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/4CSdAq&lt;/a&gt; -- &lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;Belimumab inhibits B-Lymphocyte stimulator (BLyS), also known as B cell activation factor of the TNF family (BAFF) &lt;a href="http://bit.ly/C9aEz" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/C9aEz&lt;/a&gt;&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;It can happen: Methylprednisolone-induced anaphylaxis &lt;a href="http://bit.ly/1Trki9" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/1Trki9&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;Eosinophilic panniculitis: a new form of local reaction with specific immunotherapy &lt;a href="http://bit.ly/4ev0tC" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/4ev0tC&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;Th17 immunity may be also involved in the pathogenesis of allergic asthma &lt;a href="http://bit.ly/3fIX2s" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/3fIX2s&lt;/a&gt;&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;/blockquote&gt;Medical news tweets are not research articles - they are 140-character messages - please always go to the original source, links, etc. Tweets and links do not represent endorsement, approval or support. Image source: OpenClipArt.org, public domain.&lt;br /&gt;&lt;br /&gt;&lt;a href="http://twitter.com/Allergy"&gt;Follow me&lt;/a&gt; on Twitter:&lt;br /&gt;&lt;br /&gt;&lt;script type="text/javascript" language="JavaScript" src="http://twittercounter.com/embed/?username=Allergy&amp;amp;style=bird"&gt;&lt;/script&gt;&lt;span style="font-weight: bold;"&gt;&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;p&gt;   &lt;/p&gt;

Posted at &lt;a href="http://allergynotes.blogspot.com/"&gt;Allergy Notes&lt;/a&gt;. Stay updated and &lt;a href="http://feeds.feedburner.com/AllergyNotes"&gt;subscribe&lt;/a&gt;, or follow me on &lt;a href="http://twitter.com/Allergy"&gt;Twitter&lt;/a&gt;.&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2057269305378114997-839296356832177006?l=allergynotes.blogspot.com' alt='' /&gt;&lt;/div&gt;
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/Mxj-Z3qBlyA8tiPXSV56SbTD9NU/0/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/Mxj-Z3qBlyA8tiPXSV56SbTD9NU/0/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;br/&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/Mxj-Z3qBlyA8tiPXSV56SbTD9NU/1/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/Mxj-Z3qBlyA8tiPXSV56SbTD9NU/1/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/AllergyNotes/~4/B1_awJiTvvc" height="1" width="1"/&gt;</content><link rel="replies" type="application/atom+xml" href="http://allergynotes.blogspot.com/feeds/839296356832177006/comments/default" title="Post Comments" /><link rel="replies" type="text/html" href="http://allergynotes.blogspot.com/2009/12/allergy-and-immunology-news-of-day.html#comment-form" title="0 Comments" /><link rel="edit" type="application/atom+xml" href="http://www.blogger.com/feeds/2057269305378114997/posts/default/839296356832177006?v=2" /><link rel="self" type="application/atom+xml" href="http://www.blogger.com/feeds/2057269305378114997/posts/default/839296356832177006?v=2" /><link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/AllergyNotes/~3/B1_awJiTvvc/allergy-and-immunology-news-of-day.html" title="Allergy and Immunology News of the Day" /><author><name>Ves Dimov, M.D.</name><email>noreply@blogger.com</email><gd:extendedProperty name="OpenSocialUserId" value="07511862151701001787" /></author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="http://3.bp.blogspot.com/_LY7APi0bufs/SXFDHrotv1I/AAAAAAAADTg/Jq_g36NjLeg/s72-c/Clock-2-small.jpg" height="72" width="72" /><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total><feedburner:origLink>http://allergynotes.blogspot.com/2009/12/allergy-and-immunology-news-of-day.html</feedburner:origLink></entry><entry gd:etag="W/&quot;DUQCQXk6cCp7ImA9WxNaFks.&quot;"><id>tag:blogger.com,1999:blog-2057269305378114997.post-1728619571401421688</id><published>2009-12-01T06:36:00.001-05:00</published><updated>2009-12-01T06:36:00.718-05:00</updated><app:edited xmlns:app="http://www.w3.org/2007/app">2009-12-01T06:36:00.718-05:00</app:edited><category scheme="http://www.blogger.com/atom/ns#" term="Video" /><category scheme="http://www.blogger.com/atom/ns#" term="Anaphylaxis" /><category scheme="http://www.blogger.com/atom/ns#" term="Patient Information" /><title>Video: Be Safe from Anaphylaxis</title><content type="html">From Mayo Clinic:&lt;br /&gt;&lt;br /&gt;&lt;object height="344" width="425"&gt;&lt;param name="movie" value="http://www.youtube.com/v/TTcL7u05aUU&amp;amp;hl=en_US&amp;amp;fs=1&amp;amp;"&gt;&lt;param name="allowFullScreen" value="true"&gt;&lt;param name="allowscriptaccess" value="always"&gt;&lt;embed src="http://www.youtube.com/v/TTcL7u05aUU&amp;amp;hl=en_US&amp;amp;fs=1&amp;amp;" type="application/x-shockwave-flash" allowscriptaccess="always" allowfullscreen="true" height="344" width="425"&gt;&lt;/embed&gt;&lt;/object&gt;&lt;br /&gt;&lt;br /&gt;"Every year up to two thousand people in the United States and Canada die from anaphylaxis -- a serious allergic reaction. The most common causes are allergies to peanuts, insect bites and seafood. But not all anaphylactic reactions are severe. They can be mild with subtler symptoms. And most people don't know that if you've had a mild reaction in the past, you're at risk of having a life threatening one in the future."&lt;div class="blogger-post-footer"&gt;&lt;p&gt;   &lt;/p&gt;

Posted at &lt;a href="http://allergynotes.blogspot.com/"&gt;Allergy Notes&lt;/a&gt;. Stay updated and &lt;a href="http://feeds.feedburner.com/AllergyNotes"&gt;subscribe&lt;/a&gt;, or follow me on &lt;a href="http://twitter.com/Allergy"&gt;Twitter&lt;/a&gt;.&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2057269305378114997-1728619571401421688?l=allergynotes.blogspot.com' alt='' /&gt;&lt;/div&gt;
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/lT1u3Zs_jpmpslaoRF3FSNGpa6I/0/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/lT1u3Zs_jpmpslaoRF3FSNGpa6I/0/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;br/&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/lT1u3Zs_jpmpslaoRF3FSNGpa6I/1/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/lT1u3Zs_jpmpslaoRF3FSNGpa6I/1/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/AllergyNotes/~4/deCkctCHSYY" height="1" width="1"/&gt;</content><link rel="replies" type="application/atom+xml" href="http://allergynotes.blogspot.com/feeds/1728619571401421688/comments/default" title="Post Comments" /><link rel="replies" type="text/html" href="http://allergynotes.blogspot.com/2009/12/video-be-safe-from-anaphylaxis.html#comment-form" title="0 Comments" /><link rel="edit" type="application/atom+xml" href="http://www.blogger.com/feeds/2057269305378114997/posts/default/1728619571401421688?v=2" /><link rel="self" type="application/atom+xml" href="http://www.blogger.com/feeds/2057269305378114997/posts/default/1728619571401421688?v=2" /><link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/AllergyNotes/~3/deCkctCHSYY/video-be-safe-from-anaphylaxis.html" title="Video: Be Safe from Anaphylaxis" /><author><name>Ves Dimov, M.D.</name><email>noreply@blogger.com</email><gd:extendedProperty name="OpenSocialUserId" value="07511862151701001787" /></author><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total><feedburner:origLink>http://allergynotes.blogspot.com/2009/12/video-be-safe-from-anaphylaxis.html</feedburner:origLink></entry><entry gd:etag="W/&quot;DkUMQXYyfCp7ImA9WxNaFUQ.&quot;"><id>tag:blogger.com,1999:blog-2057269305378114997.post-8445177411571549694</id><published>2009-11-30T10:18:00.001-05:00</published><updated>2009-11-30T10:18:00.894-05:00</updated><app:edited xmlns:app="http://www.w3.org/2007/app">2009-11-30T10:18:00.894-05:00</app:edited><category scheme="http://www.blogger.com/atom/ns#" term="News of the Day" /><title>Allergy and Immunology News of the Day</title><content type="html">&lt;a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="http://3.bp.blogspot.com/_LY7APi0bufs/SXFDHrotv1I/AAAAAAAADTg/Jq_g36NjLeg/s1600-h/Clock-2-small.jpg"&gt;&lt;img style="margin: 0pt 0pt 10px 10px; float: right; cursor: pointer; width: 100px; height: 100px;" src="http://3.bp.blogspot.com/_LY7APi0bufs/SXFDHrotv1I/AAAAAAAADTg/Jq_g36NjLeg/s200/Clock-2-small.jpg" alt="" id="BLOGGER_PHOTO_ID_5292084836388683602" border="0" /&gt;&lt;/a&gt; &lt;a href="http://casesblog.blogspot.com/search/label/Health%20News%20of%20the%20Day"&gt;Health News of the Day&lt;/a&gt; is a daily summary made from the &lt;a href="https://twitter.com/Allergy"&gt;selected links I post on Twitter&lt;/a&gt;. It is in a bullet points format with links to the original sources which include 350 RSS feeds that produce about 2,500 items per day.&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;&lt;/span&gt;&lt;/span&gt;&lt;blockquote&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;ICS/LABA in COPD increase risk of pneumonia by 63%, viral respiratory infections by 22%, oral fungal infections by 59%. &lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;ICS/LABA did not reduce overall death rates in COPD compared to LABA alone &lt;a href="http://bit.ly/4sDzI9" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/4sDzI9&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;Minority children less likely to take ICS for asthma, leading to more ER visits &lt;a href="http://bit.ly/4jYelC" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/4jYelC&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;Subcutaneous heparin will induce skin lesions in about one in 13 patients, usually as a result of an allergic reaction &lt;a href="http://bit.ly/VkKlb" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/VkKlb&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;Converting Advair to the equivalent Symbicort dosage - conversion table &lt;a href="http://bit.ly/2fBQCr" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/2fBQCr&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;Videos show T cells breaching the central nervous system's defences. &lt;a href="http://bit.ly/EkC3N" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/EkC3N&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;Immunology flashcards &lt;a href="http://bit.ly/2DanMh" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/2DanMh&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;CNN: "Are there any treatments for hyperthyroidism when patient is allergic to iodine?" &lt;a href="http://bit.ly/3I2NSN" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/3I2NSN&lt;/a&gt;  - There's no true iodine allergy.&lt;/span&gt;&lt;/span&gt; &lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;"Asking a patient if he/she is "allergic to iodine" should be avoided because its significance is null" &lt;a href="http://bit.ly/4Cu59e" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/4Cu59e&lt;/a&gt; -- &lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;Allergic contact dermatitis from povidone-iodine: it is important to rule out false-positive patch test reactions &lt;a href="http://bit.ly/20Y2Kf" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/20Y2Kf&lt;/a&gt;&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;Study tries to explain the relative immunity to H1N1 in people older than 60 &lt;a href="http://bit.ly/3s2Kxg" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/3s2Kxg&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;Acetaminophen, the active ingredient in Tylenol, weakens infants' immune responses to vaccines &lt;a href="http://bit.ly/4CzhTU" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/4CzhTU&lt;/a&gt;&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;/blockquote&gt;Medical news tweets are not research articles - they are 140-character messages - please always go to the original source, links, etc. Tweets and links do not represent endorsement, approval or support. Image source: OpenClipArt.org, public domain.&lt;br /&gt;&lt;br /&gt;&lt;a href="http://twitter.com/Allergy"&gt;Follow me&lt;/a&gt; on Twitter:&lt;br /&gt;&lt;br /&gt;&lt;script type="text/javascript" language="JavaScript" src="http://twittercounter.com/embed/?username=Allergy&amp;amp;style=bird"&gt;&lt;/script&gt;&lt;span style="font-weight: bold;"&gt;&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;p&gt;   &lt;/p&gt;

Posted at &lt;a href="http://allergynotes.blogspot.com/"&gt;Allergy Notes&lt;/a&gt;. Stay updated and &lt;a href="http://feeds.feedburner.com/AllergyNotes"&gt;subscribe&lt;/a&gt;, or follow me on &lt;a href="http://twitter.com/Allergy"&gt;Twitter&lt;/a&gt;.&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2057269305378114997-8445177411571549694?l=allergynotes.blogspot.com' alt='' /&gt;&lt;/div&gt;
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/ZCoVUVjInFolJlklVAVHWvjb-rM/0/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/ZCoVUVjInFolJlklVAVHWvjb-rM/0/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;br/&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/ZCoVUVjInFolJlklVAVHWvjb-rM/1/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/ZCoVUVjInFolJlklVAVHWvjb-rM/1/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/AllergyNotes/~4/hSz59qG6vco" height="1" width="1"/&gt;</content><link rel="replies" type="application/atom+xml" href="http://allergynotes.blogspot.com/feeds/8445177411571549694/comments/default" title="Post Comments" /><link rel="replies" type="text/html" href="http://allergynotes.blogspot.com/2009/11/allergy-and-immunology-news-of-day_30.html#comment-form" title="0 Comments" /><link rel="edit" type="application/atom+xml" href="http://www.blogger.com/feeds/2057269305378114997/posts/default/8445177411571549694?v=2" /><link rel="self" type="application/atom+xml" href="http://www.blogger.com/feeds/2057269305378114997/posts/default/8445177411571549694?v=2" /><link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/AllergyNotes/~3/hSz59qG6vco/allergy-and-immunology-news-of-day_30.html" title="Allergy and Immunology News of the Day" /><author><name>Ves Dimov, M.D.</name><email>noreply@blogger.com</email><gd:extendedProperty name="OpenSocialUserId" value="07511862151701001787" /></author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="http://3.bp.blogspot.com/_LY7APi0bufs/SXFDHrotv1I/AAAAAAAADTg/Jq_g36NjLeg/s72-c/Clock-2-small.jpg" height="72" width="72" /><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total><feedburner:origLink>http://allergynotes.blogspot.com/2009/11/allergy-and-immunology-news-of-day_30.html</feedburner:origLink></entry><entry gd:etag="W/&quot;AkIEQXw8eSp7ImA9WxNaFUo.&quot;"><id>tag:blogger.com,1999:blog-2057269305378114997.post-7029388550690041203</id><published>2009-11-30T05:55:00.004-05:00</published><updated>2009-11-30T05:55:00.271-05:00</updated><app:edited xmlns:app="http://www.w3.org/2007/app">2009-11-30T05:55:00.271-05:00</app:edited><category scheme="http://www.blogger.com/atom/ns#" term="Anaphylaxis" /><title>Food-Dependent Exercise-Induced Anaphylaxis (FDEIA)</title><content type="html">&lt;a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="http://photos1.blogger.com/blogger/2608/483/1600/Sport.png"&gt;&lt;img style="margin: 0pt 0pt 10px 10px; float: right; cursor: pointer;" src="http://photos1.blogger.com/blogger/2608/483/200/Sport.png" alt="" border="0" /&gt;&lt;/a&gt;Food-dependent exercise-induced anaphylaxis (FDEIA) is a special form of food allergy where a food-intake alone does not induce any symptoms. Anaphylaxis occurs only when triggering factors such as exercise or aspirin-intake are added after ingestion of the causative food.&lt;br /&gt;&lt;br /&gt;The most frequent causative food in FDEIA in Japan is wheat. Both exercise and aspirin-intake facilitate allergen absorption from the gastrointestinal tract.&lt;br /&gt;&lt;br /&gt;80% of the patients with wheat-induced FDEIA have IgE reacting to omega-5 gliadin and the remaining of the patients to high molecular weight glutenin (HMW-glutenin).&lt;br /&gt;&lt;br /&gt;References:&lt;br /&gt;&lt;a href="http://www.ncbi.nlm.nih.gov/pubmed/19847096?dopt=Abstract"&gt;Food-Dependent Exercise-Induced Anaphylaxis-Importance of Omega-5 Gliadin and HMW-Glutenin as Causative Antigens for Wheat-Dependent Exercise-Induced Anaphylaxis&lt;/a&gt;. Morita E, Matsuo H, Chinuki Y, Takahashi H, Dahlström J, Tanaka A. Allergol Int. 2009 Oct 25;58(4).&lt;div&gt;Image source: OpenClipart.org, public domain.&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;p&gt;   &lt;/p&gt;

Posted at &lt;a href="http://allergynotes.blogspot.com/"&gt;Allergy Notes&lt;/a&gt;. Stay updated and &lt;a href="http://feeds.feedburner.com/AllergyNotes"&gt;subscribe&lt;/a&gt;, or follow me on &lt;a href="http://twitter.com/Allergy"&gt;Twitter&lt;/a&gt;.&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2057269305378114997-7029388550690041203?l=allergynotes.blogspot.com' alt='' /&gt;&lt;/div&gt;
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/-INl80Req-WHzCnh_tyAHkllU1w/0/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/-INl80Req-WHzCnh_tyAHkllU1w/0/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;br/&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/-INl80Req-WHzCnh_tyAHkllU1w/1/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/-INl80Req-WHzCnh_tyAHkllU1w/1/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/AllergyNotes/~4/s2uIe99mFBM" height="1" width="1"/&gt;</content><link rel="replies" type="application/atom+xml" href="http://allergynotes.blogspot.com/feeds/7029388550690041203/comments/default" title="Post Comments" /><link rel="replies" type="text/html" href="http://allergynotes.blogspot.com/2009/11/food-dependent-exercise-induced.html#comment-form" title="0 Comments" /><link rel="edit" type="application/atom+xml" href="http://www.blogger.com/feeds/2057269305378114997/posts/default/7029388550690041203?v=2" /><link rel="self" type="application/atom+xml" href="http://www.blogger.com/feeds/2057269305378114997/posts/default/7029388550690041203?v=2" /><link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/AllergyNotes/~3/s2uIe99mFBM/food-dependent-exercise-induced.html" title="Food-Dependent Exercise-Induced Anaphylaxis (FDEIA)" /><author><name>Ves Dimov, M.D.</name><email>noreply@blogger.com</email><gd:extendedProperty name="OpenSocialUserId" value="07511862151701001787" /></author><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total><feedburner:origLink>http://allergynotes.blogspot.com/2009/11/food-dependent-exercise-induced.html</feedburner:origLink></entry><entry gd:etag="W/&quot;AkQGQX44cCp7ImA9WxNaEkk.&quot;"><id>tag:blogger.com,1999:blog-2057269305378114997.post-2530320953032793602</id><published>2009-11-26T10:12:00.002-05:00</published><updated>2009-11-26T10:12:00.038-05:00</updated><app:edited xmlns:app="http://www.w3.org/2007/app">2009-11-26T10:12:00.038-05:00</app:edited><category scheme="http://www.blogger.com/atom/ns#" term="News of the Day" /><title>Allergy and Immunology News of the Day</title><content type="html">&lt;a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="http://3.bp.blogspot.com/_LY7APi0bufs/SXFDHrotv1I/AAAAAAAADTg/Jq_g36NjLeg/s1600-h/Clock-2-small.jpg"&gt;&lt;img style="margin: 0pt 0pt 10px 10px; float: right; cursor: pointer; width: 100px; height: 100px;" src="http://3.bp.blogspot.com/_LY7APi0bufs/SXFDHrotv1I/AAAAAAAADTg/Jq_g36NjLeg/s200/Clock-2-small.jpg" alt="" id="BLOGGER_PHOTO_ID_5292084836388683602" border="0" /&gt;&lt;/a&gt; &lt;a href="http://casesblog.blogspot.com/search/label/Health%20News%20of%20the%20Day"&gt;Health News of the Day&lt;/a&gt; is a daily summary made from the &lt;a href="https://twitter.com/Allergy"&gt;selected links I post on Twitter&lt;/a&gt;. It is in a bullet points format with links to the original sources which include 350 RSS feeds that produce about 2,500 items per day.&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;&lt;/span&gt;&lt;/span&gt;&lt;blockquote&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;Among children diagnosed with multiple allergic diseases there is a number of variants of 'the allergic march'. &lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;Eczema followed by asthma, which is in turn followed by rhinitis, is the most common trajectory of the allergic march &lt;a href="http://bit.ly/GD7wK" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/GD7wK&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;Treating pregnant mothers, and then their infants, with probiotics may help prevent eczema in children &lt;a href="http://bit.ly/XcTk4" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/XcTk4&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;Bee venom immunotherapy  is effective in most patients immediately after the maintenance dose has been reached  &lt;a href="http://bit.ly/3so0zT" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/3so0zT&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;Researchers trying to create "mutant" allergens that one day may be used to treat allergy sufferers - WSJ &lt;a href="http://bit.ly/SE6ml" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/SE6ml&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;Risk of Afib may double with systemic  steroids taken for chronic diseases &lt;a href="http://bit.ly/QCL1V" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/QCL1V&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;IgE-independent hypersensitivity mediated by immunoglobulin free light chains (FLCs) &lt;a href="http://bit.ly/4lyCdU" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/4lyCdU&lt;/a&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;An adverse reaction seemingly associated with a vaccine should not preclude receiving that same vaccine in the future &lt;a href="http://bit.ly/Z1UwP" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/Z1UwP&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;Kyle and family document their trip to The Hill where they lobby for laws to manage food allergies in school - CNN &lt;a href="http://bit.ly/3fjVWA" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/3fjVWA&lt;/a&gt;&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;/blockquote&gt;Medical news tweets are not research articles - they are 140-character messages - please always go to the original source, links, etc. Tweets and links do not represent endorsement, approval or support. Image source: OpenClipArt.org, public domain.&lt;br /&gt;&lt;br /&gt;&lt;a href="http://twitter.com/Allergy"&gt;Follow me&lt;/a&gt; on Twitter:&lt;br /&gt;&lt;br /&gt;&lt;script type="text/javascript" language="JavaScript" src="http://twittercounter.com/embed/?username=Allergy&amp;amp;style=bird"&gt;&lt;/script&gt;&lt;span style="font-weight: bold;"&gt;&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;p&gt;   &lt;/p&gt;

Posted at &lt;a href="http://allergynotes.blogspot.com/"&gt;Allergy Notes&lt;/a&gt;. Stay updated and &lt;a href="http://feeds.feedburner.com/AllergyNotes"&gt;subscribe&lt;/a&gt;, or follow me on &lt;a href="http://twitter.com/Allergy"&gt;Twitter&lt;/a&gt;.&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2057269305378114997-2530320953032793602?l=allergynotes.blogspot.com' alt='' /&gt;&lt;/div&gt;
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/qKh9oZdt6Dba_mfuCfoCq744JRQ/0/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/qKh9oZdt6Dba_mfuCfoCq744JRQ/0/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;br/&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/qKh9oZdt6Dba_mfuCfoCq744JRQ/1/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/qKh9oZdt6Dba_mfuCfoCq744JRQ/1/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/AllergyNotes/~4/_wFzzHQ0JOs" height="1" width="1"/&gt;</content><link rel="replies" type="application/atom+xml" href="http://allergynotes.blogspot.com/feeds/2530320953032793602/comments/default" title="Post Comments" /><link rel="replies" type="text/html" href="http://allergynotes.blogspot.com/2009/11/allergy-and-immunology-news-of-day_26.html#comment-form" title="0 Comments" /><link rel="edit" type="application/atom+xml" href="http://www.blogger.com/feeds/2057269305378114997/posts/default/2530320953032793602?v=2" /><link rel="self" type="application/atom+xml" href="http://www.blogger.com/feeds/2057269305378114997/posts/default/2530320953032793602?v=2" /><link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/AllergyNotes/~3/_wFzzHQ0JOs/allergy-and-immunology-news-of-day_26.html" title="Allergy and Immunology News of the Day" /><author><name>Ves Dimov, M.D.</name><email>noreply@blogger.com</email><gd:extendedProperty name="OpenSocialUserId" value="07511862151701001787" /></author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="http://3.bp.blogspot.com/_LY7APi0bufs/SXFDHrotv1I/AAAAAAAADTg/Jq_g36NjLeg/s72-c/Clock-2-small.jpg" height="72" width="72" /><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total><feedburner:origLink>http://allergynotes.blogspot.com/2009/11/allergy-and-immunology-news-of-day_26.html</feedburner:origLink></entry><entry gd:etag="W/&quot;C08EQXo-cCp7ImA9WxNaEUs.&quot;"><id>tag:blogger.com,1999:blog-2057269305378114997.post-1724395843681198141</id><published>2009-11-25T10:10:00.002-05:00</published><updated>2009-11-25T10:10:00.458-05:00</updated><app:edited xmlns:app="http://www.w3.org/2007/app">2009-11-25T10:10:00.458-05:00</app:edited><category scheme="http://www.blogger.com/atom/ns#" term="News of the Day" /><title>Allergy and Immunology News of the Day</title><content type="html">&lt;a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="http://3.bp.blogspot.com/_LY7APi0bufs/SXFDHrotv1I/AAAAAAAADTg/Jq_g36NjLeg/s1600-h/Clock-2-small.jpg"&gt;&lt;img style="margin: 0pt 0pt 10px 10px; float: right; cursor: pointer; width: 100px; height: 100px;" src="http://3.bp.blogspot.com/_LY7APi0bufs/SXFDHrotv1I/AAAAAAAADTg/Jq_g36NjLeg/s200/Clock-2-small.jpg" alt="" id="BLOGGER_PHOTO_ID_5292084836388683602" border="0" /&gt;&lt;/a&gt; &lt;a href="http://casesblog.blogspot.com/search/label/Health%20News%20of%20the%20Day"&gt;Health News of the Day&lt;/a&gt; is a daily summary made from the &lt;a href="https://twitter.com/Allergy"&gt;selected links I post on Twitter&lt;/a&gt;. It is in a bullet points format with links to the original sources which include 350 RSS feeds that produce about 2,500 items per day.&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;&lt;/span&gt;&lt;/span&gt;&lt;blockquote&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;Deficiency of circulating plasmacytoid dendritic cells (pDC) during infancy appears to be a risk factor for asthma. &lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;Infants with higher numbers of circulating plasmacytoid dendritic cells (pDC) appear "protected" against asthma &lt;a href="http://bit.ly/2xUexA" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/2xUexA&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;The minimally important difference in Asthma Control Test (ACT) used for comparison between test samples is 3 points &lt;a href="http://bit.ly/hv04A" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/hv04A&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;Inhibition of IL-4–STAT6 might explain the mechanism of aspirin desensitization &lt;a href="http://bit.ly/13A9v2" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/13A9v2&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;People who clean their homes with bleach are less likely to be atopic but more likely to have respiratory symptoms. &lt;a href="http://bit.ly/nMAAj" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/nMAAj&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;Immunotherapy studies have demonstrated that a local reaction does not predict a systemic reaction. &lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;Local reactions to immunotherapy do not predict local reactions at the next immunotherapy injection. &lt;a href="http://bit.ly/WYTgN" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/WYTgN&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;Factors associated with uncontrolled asthma were different in ICS users and non-ICS users. &lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;In ICS users: chronic cough/phlegm, female sex. &lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;Factors associated with uncontrolled asthma in non-ICS users: high total IgE and sensitization to molds &lt;a href="http://bit.ly/unKon" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/unKon&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;There is a need for better designed sublingual immunotherapy (SLIT) clinical trials.&lt;span style="text-decoration: underline;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt; Several unpublished oral and sublingual immunotherapy studies in the United States failed to meet primary endpoints. &lt;a href="http://bit.ly/ttaIB" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/ttaIB&lt;/a&gt;&lt;/span&gt;&lt;/span&gt;&lt;a href="http://bit.ly/ttaIB" class="tweet-url web" rel="nofollow" target="_blank"&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/a&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;/blockquote&gt;&lt;br /&gt;Medical news tweets are not research articles - they are 140-character messages - please always go to the original source, links, etc. Tweets and links do not represent endorsement, approval or support. Image source: OpenClipArt.org, public domain.&lt;br /&gt;&lt;br /&gt;&lt;a href="http://twitter.com/Allergy"&gt;Follow me&lt;/a&gt; on Twitter:&lt;br /&gt;&lt;br /&gt;&lt;script type="text/javascript" language="JavaScript" src="http://twittercounter.com/embed/?username=Allergy&amp;amp;style=bird"&gt;&lt;/script&gt;&lt;span style="font-weight: bold;"&gt;&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;p&gt;   &lt;/p&gt;

Posted at &lt;a href="http://allergynotes.blogspot.com/"&gt;Allergy Notes&lt;/a&gt;. Stay updated and &lt;a href="http://feeds.feedburner.com/AllergyNotes"&gt;subscribe&lt;/a&gt;, or follow me on &lt;a href="http://twitter.com/Allergy"&gt;Twitter&lt;/a&gt;.&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2057269305378114997-1724395843681198141?l=allergynotes.blogspot.com' alt='' /&gt;&lt;/div&gt;
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/gAFrnEHiZlXa1mWT0sBcWj6G0EM/0/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/gAFrnEHiZlXa1mWT0sBcWj6G0EM/0/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;br/&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/gAFrnEHiZlXa1mWT0sBcWj6G0EM/1/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/gAFrnEHiZlXa1mWT0sBcWj6G0EM/1/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/AllergyNotes/~4/3v_BFdCOur8" height="1" width="1"/&gt;</content><link rel="replies" type="application/atom+xml" href="http://allergynotes.blogspot.com/feeds/1724395843681198141/comments/default" title="Post Comments" /><link rel="replies" type="text/html" href="http://allergynotes.blogspot.com/2009/11/allergy-and-immunology-news-of-day_25.html#comment-form" title="0 Comments" /><link rel="edit" type="application/atom+xml" href="http://www.blogger.com/feeds/2057269305378114997/posts/default/1724395843681198141?v=2" /><link rel="self" type="application/atom+xml" href="http://www.blogger.com/feeds/2057269305378114997/posts/default/1724395843681198141?v=2" /><link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/AllergyNotes/~3/3v_BFdCOur8/allergy-and-immunology-news-of-day_25.html" title="Allergy and Immunology News of the Day" /><author><name>Ves Dimov, M.D.</name><email>noreply@blogger.com</email><gd:extendedProperty name="OpenSocialUserId" value="07511862151701001787" /></author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="http://3.bp.blogspot.com/_LY7APi0bufs/SXFDHrotv1I/AAAAAAAADTg/Jq_g36NjLeg/s72-c/Clock-2-small.jpg" height="72" width="72" /><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total><feedburner:origLink>http://allergynotes.blogspot.com/2009/11/allergy-and-immunology-news-of-day_25.html</feedburner:origLink></entry><entry gd:etag="W/&quot;AkIAQX4yeSp7ImA9WxNaEUk.&quot;"><id>tag:blogger.com,1999:blog-2057269305378114997.post-9083040306278880288</id><published>2009-11-25T06:29:00.003-05:00</published><updated>2009-11-25T06:29:00.091-05:00</updated><app:edited xmlns:app="http://www.w3.org/2007/app">2009-11-25T06:29:00.091-05:00</app:edited><category scheme="http://www.blogger.com/atom/ns#" term="Video" /><category scheme="http://www.blogger.com/atom/ns#" term="Rhinitis" /><category scheme="http://www.blogger.com/atom/ns#" term="ACAAI" /><title>Environmental exposure chamber determines triggers in non-allergic rhinitis</title><content type="html">From &lt;a href="http://www.medpagetoday.com/MeetingCoverage/ACAAI/16901"&gt;MedPage Today&lt;/a&gt;:&lt;br /&gt;&lt;br /&gt;&lt;iframe src="http://www.medpagetoday.com/Medpage-Player/16901/" marginheight="0" marginwidth="0" id="mptplayer" width="320" frameborder="0" height="265" scrolling="no"&gt;&lt;/iframe&gt;&lt;script&gt; window.onload = function () { var q = (document.URL); document.getElementById("mptplayer").src += q; } &lt;/script&gt;&lt;br /&gt;&lt;br /&gt;In a study of 41 patients with non-allergic rhinitis exposed sequentially to a range of triggers, researchers found:&lt;br /&gt;&lt;br /&gt;- 51% responded to cold dry air&lt;br /&gt;- 70% reacted to a change from warm humid air to cold and dry air&lt;br /&gt;- 47% responded to a two-hour exposure to ozone&lt;br /&gt;- 32% responded to a 15-minute exposure to acetic acid, described as "smelling like a fish and chip shop"&lt;br /&gt;- 43% responded to a potpourri fragrance&lt;br /&gt;&lt;br /&gt;References:&lt;br /&gt;&lt;a href="http://www.medpagetoday.com/MeetingCoverage/ACAAI/16901"&gt;ACAAI: New Method Tackles Nonallergic Rhinitis&lt;/a&gt;. Michael Smith, North American Correspondent, MedPage Today.&lt;div class="blogger-post-footer"&gt;&lt;p&gt;   &lt;/p&gt;

Posted at &lt;a href="http://allergynotes.blogspot.com/"&gt;Allergy Notes&lt;/a&gt;. Stay updated and &lt;a href="http://feeds.feedburner.com/AllergyNotes"&gt;subscribe&lt;/a&gt;, or follow me on &lt;a href="http://twitter.com/Allergy"&gt;Twitter&lt;/a&gt;.&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2057269305378114997-9083040306278880288?l=allergynotes.blogspot.com' alt='' /&gt;&lt;/div&gt;
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/JJlADvW5WL7yXccnpeDkt-a7E2M/0/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/JJlADvW5WL7yXccnpeDkt-a7E2M/0/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;br/&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/JJlADvW5WL7yXccnpeDkt-a7E2M/1/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/JJlADvW5WL7yXccnpeDkt-a7E2M/1/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/AllergyNotes/~4/XXe7YPe5BYM" height="1" width="1"/&gt;</content><link rel="replies" type="application/atom+xml" href="http://allergynotes.blogspot.com/feeds/9083040306278880288/comments/default" title="Post Comments" /><link rel="replies" type="text/html" href="http://allergynotes.blogspot.com/2009/11/environmental-exposure-chamber.html#comment-form" title="0 Comments" /><link rel="edit" type="application/atom+xml" href="http://www.blogger.com/feeds/2057269305378114997/posts/default/9083040306278880288?v=2" /><link rel="self" type="application/atom+xml" href="http://www.blogger.com/feeds/2057269305378114997/posts/default/9083040306278880288?v=2" /><link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/AllergyNotes/~3/XXe7YPe5BYM/environmental-exposure-chamber.html" title="Environmental exposure chamber determines triggers in non-allergic rhinitis" /><author><name>Ves Dimov, M.D.</name><email>noreply@blogger.com</email><gd:extendedProperty name="OpenSocialUserId" value="07511862151701001787" /></author><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total><feedburner:origLink>http://allergynotes.blogspot.com/2009/11/environmental-exposure-chamber.html</feedburner:origLink></entry><entry gd:etag="W/&quot;D0UMQXgzeSp7ImA9WxNaEEo.&quot;"><id>tag:blogger.com,1999:blog-2057269305378114997.post-4205035303141973066</id><published>2009-11-24T10:08:00.002-05:00</published><updated>2009-11-24T10:08:00.681-05:00</updated><app:edited xmlns:app="http://www.w3.org/2007/app">2009-11-24T10:08:00.681-05:00</app:edited><category scheme="http://www.blogger.com/atom/ns#" term="News of the Day" /><title>Allergy and Immunology News of the Day</title><content type="html">&lt;a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="http://3.bp.blogspot.com/_LY7APi0bufs/SXFDHrotv1I/AAAAAAAADTg/Jq_g36NjLeg/s1600-h/Clock-2-small.jpg"&gt;&lt;img style="margin: 0pt 0pt 10px 10px; float: right; cursor: pointer; width: 100px; height: 100px;" src="http://3.bp.blogspot.com/_LY7APi0bufs/SXFDHrotv1I/AAAAAAAADTg/Jq_g36NjLeg/s200/Clock-2-small.jpg" alt="" id="BLOGGER_PHOTO_ID_5292084836388683602" border="0" /&gt;&lt;/a&gt; &lt;a href="http://casesblog.blogspot.com/search/label/Health%20News%20of%20the%20Day"&gt;Health News of the Day&lt;/a&gt; is a daily summary made from the &lt;a href="https://twitter.com/Allergy"&gt;selected links I post on Twitter&lt;/a&gt;. It is in a bullet points format with links to the original sources which include 350 RSS feeds that produce about 2,500 items per day.&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;&lt;/span&gt;&lt;/span&gt;&lt;blockquote&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;Being overweight, especially around the middle, linked to risk for developing asthma  &lt;a href="http://bit.ly/pEmSZ" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/pEmSZ&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;Normal reference values for serum mast cell tryptase are 1-15 ng/mL, with an average of approximately 5 ng/mL &lt;a href="http://bit.ly/cTSYL" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/cTSYL&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;Incidence of anaphylaxis has increased over the past few decades, lifetime prevalence is 0.05% to 2.0%. &lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;Higher incidence of pediatric anaphylaxis in northern areas of the United States &lt;a href="http://bit.ly/3lxAhd" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/3lxAhd&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;C1 esterase inhibitor 20 U/kg IV  is effective, rapid and safe treatment for acute abdominal and facial attacks in HAE &lt;a href="http://bit.ly/ag64n" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/ag64n&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;IL-2, IL-6, IL-10, TNF receptor I, MCT, and histamine were significantly elevated in patients with severe anaphylaxis. &lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;Levels of IL-6, IL-10, TNF receptor I, MCT, and histamine correlated with hypotension in anaphylaxis &lt;a href="http://bit.ly/vKHI" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/vKHI&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;Lipid transfer protein (Ara h 9) as a new peanut allergen relevant for a Mediterranean allergic population &lt;a href="http://bit.ly/mLA4m" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/mLA4m&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;Expression of CCR5 and CCR6 of Langerin-negative CD1a+ dendritic cells was characteristic for acute atopic dermatitis &lt;a href="http://bit.ly/1QuOCo" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/1QuOCo&lt;/a&gt;&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;A wasp in a sticky situation in Milton Keynes.  &lt;a href="http://bit.ly/4cBJTx" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/4cBJTx&lt;/a&gt;&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;ACP has created a COPD Portal &lt;a href="http://bit.ly/2X7jC" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/2X7jC&lt;/a&gt;&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;/blockquote&gt;Medical news tweets are not research articles - they are 140-character messages - please always go to the original source, links, etc. Tweets and links do not represent endorsement, approval or support. Image source: OpenClipArt.org, public domain.&lt;br /&gt;&lt;br /&gt;&lt;a href="http://twitter.com/Allergy"&gt;Follow me&lt;/a&gt; on Twitter:&lt;br /&gt;&lt;br /&gt;&lt;script type="text/javascript" language="JavaScript" src="http://twittercounter.com/embed/?username=Allergy&amp;amp;style=bird"&gt;&lt;/script&gt;&lt;span style="font-weight: bold;"&gt;&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;p&gt;   &lt;/p&gt;

Posted at &lt;a href="http://allergynotes.blogspot.com/"&gt;Allergy Notes&lt;/a&gt;. Stay updated and &lt;a href="http://feeds.feedburner.com/AllergyNotes"&gt;subscribe&lt;/a&gt;, or follow me on &lt;a href="http://twitter.com/Allergy"&gt;Twitter&lt;/a&gt;.&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2057269305378114997-4205035303141973066?l=allergynotes.blogspot.com' alt='' /&gt;&lt;/div&gt;
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/h-9-nUUlnvJoLNmmGJgu3FZFHQg/0/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/h-9-nUUlnvJoLNmmGJgu3FZFHQg/0/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;br/&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/h-9-nUUlnvJoLNmmGJgu3FZFHQg/1/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/h-9-nUUlnvJoLNmmGJgu3FZFHQg/1/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/AllergyNotes/~4/8EsAbIkF4h4" height="1" width="1"/&gt;</content><link rel="replies" type="application/atom+xml" href="http://allergynotes.blogspot.com/feeds/4205035303141973066/comments/default" title="Post Comments" /><link rel="replies" type="text/html" href="http://allergynotes.blogspot.com/2009/11/allergy-and-immunology-news-of-day_24.html#comment-form" title="0 Comments" /><link rel="edit" type="application/atom+xml" href="http://www.blogger.com/feeds/2057269305378114997/posts/default/4205035303141973066?v=2" /><link rel="self" type="application/atom+xml" href="http://www.blogger.com/feeds/2057269305378114997/posts/default/4205035303141973066?v=2" /><link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/AllergyNotes/~3/8EsAbIkF4h4/allergy-and-immunology-news-of-day_24.html" title="Allergy and Immunology News of the Day" /><author><name>Ves Dimov, M.D.</name><email>noreply@blogger.com</email><gd:extendedProperty name="OpenSocialUserId" value="07511862151701001787" /></author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="http://3.bp.blogspot.com/_LY7APi0bufs/SXFDHrotv1I/AAAAAAAADTg/Jq_g36NjLeg/s72-c/Clock-2-small.jpg" height="72" width="72" /><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total><feedburner:origLink>http://allergynotes.blogspot.com/2009/11/allergy-and-immunology-news-of-day_24.html</feedburner:origLink></entry><entry gd:etag="W/&quot;CU4AQXo4eCp7ImA9WxNaEEs.&quot;"><id>tag:blogger.com,1999:blog-2057269305378114997.post-3494792276624802915</id><published>2009-11-24T06:59:00.001-05:00</published><updated>2009-11-24T06:59:00.430-05:00</updated><app:edited xmlns:app="http://www.w3.org/2007/app">2009-11-24T06:59:00.430-05:00</app:edited><category scheme="http://www.blogger.com/atom/ns#" term="SCIT" /><category scheme="http://www.blogger.com/atom/ns#" term="SLIT" /><category scheme="http://www.blogger.com/atom/ns#" term="Immunotherapy" /><title>Adherence to allergen-specific immunotherapy is better for SLIT than SCIT</title><content type="html">&lt;a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="http://4.bp.blogspot.com/_LY7APi0bufs/RtBNJWG4G9I/AAAAAAAABo8/AExu34OvtG0/s1600-h/Syringe1.jpg"&gt;&lt;img style="margin: 0pt 0pt 10px 10px; float: right; cursor: pointer;" src="http://4.bp.blogspot.com/_LY7APi0bufs/RtBNJWG4G9I/AAAAAAAABo8/AExu34OvtG0/s200/Syringe1.jpg" alt="" id="BLOGGER_PHOTO_ID_5102663200759356370" border="0" /&gt;&lt;/a&gt;Allergen-specific immunotherapy can modify the natural history of the allergic diseases, reducing the development of asthma and new sensitizations after 3-4 years of treatment. In order for immunoterapy to work however, adherence to the therapy is mandatory.&lt;br /&gt;&lt;br /&gt;Rate of adherence to subcutaneous immunotherapy (SCIT) is low, at less than 70%. The possible explanations for that fact include the following factors:&lt;br /&gt;&lt;br /&gt;- inconvenience&lt;br /&gt;- lack of perceived efficacy&lt;br /&gt;- costs and loss of working hours&lt;br /&gt;&lt;br /&gt;In comparison, local nasal immunotherapy has a even lower adherence rate (27%), due to the local nasal side effects.&lt;br /&gt;&lt;br /&gt;For sublingual immunotherapy (SLIT), the rates of compliance are greater than 75%.&lt;br /&gt;&lt;br /&gt;The reasons for discontinuation of SLIT are:&lt;br /&gt;&lt;br /&gt;- costs&lt;br /&gt;- inconvenience&lt;br /&gt;- feeling of inefficacy&lt;br /&gt;- side effects&lt;br /&gt;&lt;br /&gt;In real life, costs and patient education are crucial issues in adherence to this SCIT and SLIT. Reduction of costs and more efforts in education of patients may improve the adherence to immunotherapy.&lt;br /&gt;&lt;br /&gt;References:&lt;br /&gt;&lt;a href="http://www.ncbi.nlm.nih.gov/pubmed/19823080"&gt;Evidence of adherence to allergen-specific immunotherapy&lt;/a&gt;. Senna G, Ridolo E, Calderon M, Lombardi C, Canonica GW, Passalacqua G. Curr Opin Allergy Clin Immunol. 2009 Dec;9(6):544-8.&lt;br /&gt;Image source: OpenClipArt.org, public domain.&lt;div class="blogger-post-footer"&gt;&lt;p&gt;   &lt;/p&gt;

Posted at &lt;a href="http://allergynotes.blogspot.com/"&gt;Allergy Notes&lt;/a&gt;. Stay updated and &lt;a href="http://feeds.feedburner.com/AllergyNotes"&gt;subscribe&lt;/a&gt;, or follow me on &lt;a href="http://twitter.com/Allergy"&gt;Twitter&lt;/a&gt;.&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2057269305378114997-3494792276624802915?l=allergynotes.blogspot.com' alt='' /&gt;&lt;/div&gt;
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/4DiD6_ZwDX3j_u3PGkCepW_Kj3E/0/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/4DiD6_ZwDX3j_u3PGkCepW_Kj3E/0/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;br/&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/4DiD6_ZwDX3j_u3PGkCepW_Kj3E/1/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/4DiD6_ZwDX3j_u3PGkCepW_Kj3E/1/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/AllergyNotes/~4/vrKGrt1OhWw" height="1" width="1"/&gt;</content><link rel="replies" type="application/atom+xml" href="http://allergynotes.blogspot.com/feeds/3494792276624802915/comments/default" title="Post Comments" /><link rel="replies" type="text/html" href="http://allergynotes.blogspot.com/2009/11/adherence-to-allergen-specific.html#comment-form" title="0 Comments" /><link rel="edit" type="application/atom+xml" href="http://www.blogger.com/feeds/2057269305378114997/posts/default/3494792276624802915?v=2" /><link rel="self" type="application/atom+xml" href="http://www.blogger.com/feeds/2057269305378114997/posts/default/3494792276624802915?v=2" /><link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/AllergyNotes/~3/vrKGrt1OhWw/adherence-to-allergen-specific.html" title="Adherence to allergen-specific immunotherapy is better for SLIT than SCIT" /><author><name>Ves Dimov, M.D.</name><email>noreply@blogger.com</email><gd:extendedProperty name="OpenSocialUserId" value="07511862151701001787" /></author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="http://4.bp.blogspot.com/_LY7APi0bufs/RtBNJWG4G9I/AAAAAAAABo8/AExu34OvtG0/s72-c/Syringe1.jpg" height="72" width="72" /><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total><feedburner:origLink>http://allergynotes.blogspot.com/2009/11/adherence-to-allergen-specific.html</feedburner:origLink></entry><entry gd:etag="W/&quot;AkAEQXgzfyp7ImA9WxNbGUU.&quot;"><id>tag:blogger.com,1999:blog-2057269305378114997.post-8881743777871294970</id><published>2009-11-23T10:05:00.001-05:00</published><updated>2009-11-23T10:05:00.687-05:00</updated><app:edited xmlns:app="http://www.w3.org/2007/app">2009-11-23T10:05:00.687-05:00</app:edited><category scheme="http://www.blogger.com/atom/ns#" term="News of the Day" /><title>Allergy and Immunology News of the Day</title><content type="html">&lt;a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="http://3.bp.blogspot.com/_LY7APi0bufs/SXFDHrotv1I/AAAAAAAADTg/Jq_g36NjLeg/s1600-h/Clock-2-small.jpg"&gt;&lt;img style="margin: 0pt 0pt 10px 10px; float: right; cursor: pointer; width: 100px; height: 100px;" src="http://3.bp.blogspot.com/_LY7APi0bufs/SXFDHrotv1I/AAAAAAAADTg/Jq_g36NjLeg/s200/Clock-2-small.jpg" alt="" id="BLOGGER_PHOTO_ID_5292084836388683602" border="0" /&gt;&lt;/a&gt; &lt;a href="http://casesblog.blogspot.com/search/label/Health%20News%20of%20the%20Day"&gt;Health News of the Day&lt;/a&gt; is a daily summary made from the &lt;a href="https://twitter.com/Allergy"&gt;selected links I post on Twitter&lt;/a&gt;. It is in a bullet points format with links to the original sources which include 350 RSS feeds that produce about 2,500 items per day.&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;&lt;/span&gt;&lt;/span&gt;&lt;blockquote&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;The Claim: With a Runny Nose, Green Calls for an Antibiotic.  &lt;a href="http://bit.ly/1gD5ka" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/1gD5ka&lt;/a&gt; - Answer: Not really.&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;Arg16 genotype associated with exacerbations in asthmatic children and young adults exposed daily to beta(2)-agonists &lt;a href="http://bit.ly/2lvW7A" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/2lvW7A&lt;/a&gt;&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;Alarmin - Alarmin(g) news about danger - cells release high-mobility-group box (HMGB) proteins that signal tissue damage &lt;a href="http://bit.ly/uw725" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/uw725&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;Mammalian target of rapamycin (mTOR) is a serine–threonine kinase that senses nutrition status to control cell growth &lt;a href="http://bit.ly/BSgjs" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/BSgjs&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;Pulmonary alveolar proteinosis (PAP) is rare: accumulation of pulmonary surfactant, respiratory failure, infections. &lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;Pulmonary alveolar proteinosis is a primary immunodeficiency of impaired GM-CSF stimulation of macrophages &lt;a href="http://bit.ly/WgJe9" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/WgJe9&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;Regulatory T Cells in Asthma:  ability to enhance regulatory function may represent a treatment for asthma &lt;a href="http://bit.ly/SwUlc" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/SwUlc&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;New research: Forkhead box transcription factor Foxo and the cycle of life and death  &lt;a href="http://bit.ly/r27nr" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/r27nr&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;Properdin, a plasma component, is critical in the stabilization of alternative complement pathway convertases. &lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;Properdin is a pattern recognition molecule that binds to certain microbial surfaces, apoptotic and necrotic cells &lt;a href="http://bit.ly/2lSfaY" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/2lSfaY&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;Dogs are getting food allergies too &lt;a href="http://bit.ly/iVOjM" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/iVOjM&lt;/a&gt;&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;/blockquote&gt;Medical news tweets are not research articles - they are 140-character messages - please always go to the original source, links, etc. Tweets and links do not represent endorsement, approval or support. Image source: OpenClipArt.org, public domain.&lt;br /&gt;&lt;br /&gt;&lt;a href="http://twitter.com/Allergy"&gt;Follow me&lt;/a&gt; on Twitter:&lt;br /&gt;&lt;br /&gt;&lt;script type="text/javascript" language="JavaScript" src="http://twittercounter.com/embed/?username=Allergy&amp;amp;style=bird"&gt;&lt;/script&gt;&lt;span style="font-weight: bold;"&gt;&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;p&gt;   &lt;/p&gt;

Posted at &lt;a href="http://allergynotes.blogspot.com/"&gt;Allergy Notes&lt;/a&gt;. Stay updated and &lt;a href="http://feeds.feedburner.com/AllergyNotes"&gt;subscribe&lt;/a&gt;, or follow me on &lt;a href="http://twitter.com/Allergy"&gt;Twitter&lt;/a&gt;.&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2057269305378114997-8881743777871294970?l=allergynotes.blogspot.com' alt='' /&gt;&lt;/div&gt;
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/11UrT3mcowGhJOZ7KYM-khASHRg/0/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/11UrT3mcowGhJOZ7KYM-khASHRg/0/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;br/&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/11UrT3mcowGhJOZ7KYM-khASHRg/1/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/11UrT3mcowGhJOZ7KYM-khASHRg/1/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/AllergyNotes/~4/_U3wjJF5DXA" height="1" width="1"/&gt;</content><link rel="replies" type="application/atom+xml" href="http://allergynotes.blogspot.com/feeds/8881743777871294970/comments/default" title="Post Comments" /><link rel="replies" type="text/html" href="http://allergynotes.blogspot.com/2009/11/allergy-and-immunology-news-of-day_23.html#comment-form" title="0 Comments" /><link rel="edit" type="application/atom+xml" href="http://www.blogger.com/feeds/2057269305378114997/posts/default/8881743777871294970?v=2" /><link rel="self" type="application/atom+xml" href="http://www.blogger.com/feeds/2057269305378114997/posts/default/8881743777871294970?v=2" /><link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/AllergyNotes/~3/_U3wjJF5DXA/allergy-and-immunology-news-of-day_23.html" title="Allergy and Immunology News of the Day" /><author><name>Ves Dimov, M.D.</name><email>noreply@blogger.com</email><gd:extendedProperty name="OpenSocialUserId" value="07511862151701001787" /></author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="http://3.bp.blogspot.com/_LY7APi0bufs/SXFDHrotv1I/AAAAAAAADTg/Jq_g36NjLeg/s72-c/Clock-2-small.jpg" height="72" width="72" /><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total><feedburner:origLink>http://allergynotes.blogspot.com/2009/11/allergy-and-immunology-news-of-day_23.html</feedburner:origLink></entry><entry gd:etag="W/&quot;D0QMQX06cSp7ImA9WxNbGUo.&quot;"><id>tag:blogger.com,1999:blog-2057269305378114997.post-3246246851579640289</id><published>2009-11-23T06:23:00.000-05:00</published><updated>2009-11-23T06:23:00.319-05:00</updated><app:edited xmlns:app="http://www.w3.org/2007/app">2009-11-23T06:23:00.319-05:00</app:edited><category scheme="http://www.blogger.com/atom/ns#" term="Vaccines" /><category scheme="http://www.blogger.com/atom/ns#" term="Immunizations" /><category scheme="http://www.blogger.com/atom/ns#" term="Food Allergy" /><title>Patients who are allergic to eggs may still receive the flu shot after an allergist evaluation</title><content type="html">From &lt;a href="http://www.medpagetoday.com/MeetingCoverage/ACAAI/16877"&gt;MedPage Today&lt;/a&gt;:&lt;br /&gt;&lt;br /&gt;&lt;iframe src="http://www.medpagetoday.com/Medpage-Player/16877/" marginheight="0" marginwidth="0" id="mptplayer" width="320" frameborder="0" height="265" scrolling="no"&gt;&lt;/iframe&gt;&lt;script&gt; window.onload = function () { var q = (document.URL); document.getElementById("mptplayer").src += q; } &lt;/script&gt;&lt;br /&gt;&lt;br /&gt;"Egg-allergic patients can get a flu shot if its egg protein content is 1.2 mcg/mL or less. It should, however, be given in graded doses -- an initial 10% of the full dose, then the remaining 90% a half-hour later if no reaction occurs.&lt;br /&gt;&lt;br /&gt;Unlike MMR vaccine, which is made in chick embryo fibroblast cell cultures, influenza viruses are grown directly in eggs, so by the time it turns into the 'flu shot,' there is a little egg protein left over."&lt;br /&gt;&lt;br /&gt;References:&lt;br /&gt;&lt;a href="http://www.medpagetoday.com/MeetingCoverage/ACAAI/16877"&gt;ACAAI: Egg Allergy No Excuse for Skipping Flu Shot&lt;/a&gt;. Kristina Fiore, Staff Writer, MedPage Today.&lt;div class="blogger-post-footer"&gt;&lt;p&gt;   &lt;/p&gt;

Posted at &lt;a href="http://allergynotes.blogspot.com/"&gt;Allergy Notes&lt;/a&gt;. Stay updated and &lt;a href="http://feeds.feedburner.com/AllergyNotes"&gt;subscribe&lt;/a&gt;, or follow me on &lt;a href="http://twitter.com/Allergy"&gt;Twitter&lt;/a&gt;.&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2057269305378114997-3246246851579640289?l=allergynotes.blogspot.com' alt='' /&gt;&lt;/div&gt;
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/bJj2MXaW8nH2gu2-UuPP2snfI3s/0/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/bJj2MXaW8nH2gu2-UuPP2snfI3s/0/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;br/&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/bJj2MXaW8nH2gu2-UuPP2snfI3s/1/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/bJj2MXaW8nH2gu2-UuPP2snfI3s/1/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/AllergyNotes/~4/VMhh_5C6WcI" height="1" width="1"/&gt;</content><link rel="replies" type="application/atom+xml" href="http://allergynotes.blogspot.com/feeds/3246246851579640289/comments/default" title="Post Comments" /><link rel="replies" type="text/html" href="http://allergynotes.blogspot.com/2009/11/patients-who-are-allergic-to-eggs-may.html#comment-form" title="0 Comments" /><link rel="edit" type="application/atom+xml" href="http://www.blogger.com/feeds/2057269305378114997/posts/default/3246246851579640289?v=2" /><link rel="self" type="application/atom+xml" href="http://www.blogger.com/feeds/2057269305378114997/posts/default/3246246851579640289?v=2" /><link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/AllergyNotes/~3/VMhh_5C6WcI/patients-who-are-allergic-to-eggs-may.html" title="Patients who are allergic to eggs may still receive the flu shot after an allergist evaluation" /><author><name>Ves Dimov, M.D.</name><email>noreply@blogger.com</email><gd:extendedProperty name="OpenSocialUserId" value="07511862151701001787" /></author><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total><feedburner:origLink>http://allergynotes.blogspot.com/2009/11/patients-who-are-allergic-to-eggs-may.html</feedburner:origLink></entry><entry gd:etag="W/&quot;C08MQX05fip7ImA9WxNbGU0.&quot;"><id>tag:blogger.com,1999:blog-2057269305378114997.post-1309763566258601876</id><published>2009-11-22T09:58:00.003-05:00</published><updated>2009-11-22T09:58:00.326-05:00</updated><app:edited xmlns:app="http://www.w3.org/2007/app">2009-11-22T09:58:00.326-05:00</app:edited><category scheme="http://www.blogger.com/atom/ns#" term="News of the Day" /><title>Allergy and Immunology News of the Day</title><content type="html">&lt;a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="http://3.bp.blogspot.com/_LY7APi0bufs/SXFDHrotv1I/AAAAAAAADTg/Jq_g36NjLeg/s1600-h/Clock-2-small.jpg"&gt;&lt;img style="margin: 0pt 0pt 10px 10px; float: right; cursor: pointer; width: 100px; height: 100px;" src="http://3.bp.blogspot.com/_LY7APi0bufs/SXFDHrotv1I/AAAAAAAADTg/Jq_g36NjLeg/s200/Clock-2-small.jpg" alt="" id="BLOGGER_PHOTO_ID_5292084836388683602" border="0" /&gt;&lt;/a&gt; &lt;a href="http://casesblog.blogspot.com/search/label/Health%20News%20of%20the%20Day"&gt;Health News of the Day&lt;/a&gt; is a daily summary made from the &lt;a href="https://twitter.com/Allergy"&gt;selected links I post on Twitter&lt;/a&gt;. It is in a bullet points format with links to the original sources which include 350 RSS feeds that produce about 2,500 items per day.&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;&lt;/span&gt;&lt;/span&gt;&lt;blockquote&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;Intralymphatic immunotherapy (ILIT) reduces the dose and the number of allergen injections &lt;a href="http://bit.ly/QXzz9" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/QXzz9&lt;/a&gt;&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;Allergic disorders may be associated with microalbuminuria in men with type 2 diabetes. &lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;Blood eosinophil count is a better predictor of microalbuminuria than blood pressure, HbA1c, or duration of diabetes &lt;a href="http://bit.ly/qeQN2" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/qeQN2&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;T cells require Foxo1 transcription factor to populate the peripheral lymphoid organs &lt;a href="http://bit.ly/r5s26" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/r5s26&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;Thymic stromal lymphopoietin (TSLP) is a critical mediator of IL-13-driven allergic inflammation&lt;a href="http://bit.ly/4DzZvL" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/4DzZvL&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;The occupant as a source of house dust bacteria: human-derived bacteria account for 69-88% of mattress dust samples &lt;a href="http://bit.ly/10lJDF" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/10lJDF&lt;/a&gt;&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;Interleukin-33 – cytokine of dual function or novel alarmin?  IL-33 is a ligand for the Th2-associated ST2 receptor &lt;a href="http://bit.ly/kblld" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/kblld&lt;/a&gt;&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;New and Existing Therapeutic Options for Hand Eczema - Medscape Skin Therapy Letter &lt;a href="http://bit.ly/rYzVx" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/rYzVx&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;Allergic rhinitis with negative skin tests: Does it exist? Is localized IgE-mediated allergy in play?  &lt;a href="http://bit.ly/FfKdF" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/FfKdF&lt;/a&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;/blockquote&gt;Medical news tweets are not research articles - they are 140-character messages - please always go to the original source, links, etc. Tweets and links do not represent endorsement, approval or support. Image source: OpenClipArt.org, public domain.&lt;div class="blogger-post-footer"&gt;&lt;p&gt;   &lt;/p&gt;

Posted at &lt;a href="http://allergynotes.blogspot.com/"&gt;Allergy Notes&lt;/a&gt;. Stay updated and &lt;a href="http://feeds.feedburner.com/AllergyNotes"&gt;subscribe&lt;/a&gt;, or follow me on &lt;a href="http://twitter.com/Allergy"&gt;Twitter&lt;/a&gt;.&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2057269305378114997-1309763566258601876?l=allergynotes.blogspot.com' alt='' /&gt;&lt;/div&gt;
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/gUwy_yjfae6_7dW7FVAmDqD5urQ/0/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/gUwy_yjfae6_7dW7FVAmDqD5urQ/0/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;br/&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/gUwy_yjfae6_7dW7FVAmDqD5urQ/1/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/gUwy_yjfae6_7dW7FVAmDqD5urQ/1/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/AllergyNotes/~4/a-qlHS6jDpc" height="1" width="1"/&gt;</content><link rel="replies" type="application/atom+xml" href="http://allergynotes.blogspot.com/feeds/1309763566258601876/comments/default" title="Post Comments" /><link rel="replies" type="text/html" href="http://allergynotes.blogspot.com/2009/11/allergy-and-immunology-news-of-day_22.html#comment-form" title="0 Comments" /><link rel="edit" type="application/atom+xml" href="http://www.blogger.com/feeds/2057269305378114997/posts/default/1309763566258601876?v=2" /><link rel="self" type="application/atom+xml" href="http://www.blogger.com/feeds/2057269305378114997/posts/default/1309763566258601876?v=2" /><link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/AllergyNotes/~3/a-qlHS6jDpc/allergy-and-immunology-news-of-day_22.html" title="Allergy and Immunology News of the Day" /><author><name>Ves Dimov, M.D.</name><email>noreply@blogger.com</email><gd:extendedProperty name="OpenSocialUserId" value="07511862151701001787" /></author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="http://3.bp.blogspot.com/_LY7APi0bufs/SXFDHrotv1I/AAAAAAAADTg/Jq_g36NjLeg/s72-c/Clock-2-small.jpg" height="72" width="72" /><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total><feedburner:origLink>http://allergynotes.blogspot.com/2009/11/allergy-and-immunology-news-of-day_22.html</feedburner:origLink></entry><entry gd:etag="W/&quot;D0UAQX86fCp7ImA9WxNbGEw.&quot;"><id>tag:blogger.com,1999:blog-2057269305378114997.post-7840365784742235236</id><published>2009-11-21T09:54:00.002-05:00</published><updated>2009-11-21T09:54:00.114-05:00</updated><app:edited xmlns:app="http://www.w3.org/2007/app">2009-11-21T09:54:00.114-05:00</app:edited><category scheme="http://www.blogger.com/atom/ns#" term="News of the Day" /><title>Allergy and Immunology News of the Day</title><content type="html">&lt;a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="http://3.bp.blogspot.com/_LY7APi0bufs/SXFDHrotv1I/AAAAAAAADTg/Jq_g36NjLeg/s1600-h/Clock-2-small.jpg"&gt;&lt;img style="margin: 0pt 0pt 10px 10px; float: right; cursor: pointer; width: 100px; height: 100px;" src="http://3.bp.blogspot.com/_LY7APi0bufs/SXFDHrotv1I/AAAAAAAADTg/Jq_g36NjLeg/s200/Clock-2-small.jpg" alt="" id="BLOGGER_PHOTO_ID_5292084836388683602" border="0" /&gt;&lt;/a&gt; &lt;a href="http://casesblog.blogspot.com/search/label/Health%20News%20of%20the%20Day"&gt;Health News of the Day&lt;/a&gt; is a daily summary made from the &lt;a href="https://twitter.com/Allergy"&gt;selected links I post on Twitter&lt;/a&gt;. It is in a bullet points format with links to the original sources which include 350 RSS feeds that produce about 2,500 items per day.&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;&lt;/span&gt;&lt;/span&gt;&lt;blockquote&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;Levalbuterol versus albuterol: no clinical superiority was proven &lt;a href="http://bit.ly/1UzHLo" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/1UzHLo&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;Registration for the 2010 ABAI exams starts January 1st via the web portal &lt;a href="http://bit.ly/4ynXRS" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/4ynXRS&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;High-dose SLIT with 5 grasses  (Oralair Grasses) decreases rhinitis symptoms from the first month of treatment forward. &lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;Oralair Grasses by Stallergenes includes 5 grasses: orchard, meadow, perennial rye, sweet vernal and timothy  &lt;a href="http://bit.ly/soFU0" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/soFU0&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;Unilateral Rhinorrhea in Allergic Rhinitis Due to... Cerebrospinal Fluid Leak &lt;a href="http://bit.ly/3WycEP" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/3WycEP&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;Antismoking drug Chantix has been linked to suicide but a new study shows that such risk is nonexistent or small &lt;a href="http://bit.ly/Pijaf" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/Pijaf&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;ABAI Board Review Course online &lt;a href="http://bit.ly/cukSf" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/cukSf&lt;/a&gt; and PDFs &lt;a href="http://bit.ly/183QYt" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/183QYt&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;100 Worst Cities for Fall Allergies &lt;a href="http://bit.ly/2SrIir" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/2SrIir&lt;/a&gt;&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;RT @&lt;a class="tweet-url username" href="http://twitter.com/AllergyZoneCEO"&gt;AllergyZoneCEO&lt;/a&gt;: "Projected 20% growth in out-patient visits in next 10 years. 500M will be eVisits. Can Twitter play a role?"&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;In children with a cough that lasts more than 8 weeks, the most likely causes are allergy (?), reflux, and asthma &lt;a href="http://bit.ly/3vAk8B" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/3vAk8B&lt;/a&gt;&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;/blockquote&gt;Medical news tweets are not research articles - they are 140-character messages - please always go to the original source, links, etc. Tweets and links do not represent endorsement, approval or support. Image source: OpenClipArt.org, public domain.&lt;br /&gt;&lt;br /&gt;&lt;a href="http://twitter.com/Allergy"&gt;Follow me&lt;/a&gt; on Twitter:&lt;br /&gt;&lt;br /&gt;&lt;script type="text/javascript" language="JavaScript" src="http://twittercounter.com/embed/?username=Allergy&amp;amp;style=bird"&gt;&lt;/script&gt;&lt;span style="font-weight: bold;"&gt;&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;p&gt;   &lt;/p&gt;

Posted at &lt;a href="http://allergynotes.blogspot.com/"&gt;Allergy Notes&lt;/a&gt;. Stay updated and &lt;a href="http://feeds.feedburner.com/AllergyNotes"&gt;subscribe&lt;/a&gt;, or follow me on &lt;a href="http://twitter.com/Allergy"&gt;Twitter&lt;/a&gt;.&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2057269305378114997-7840365784742235236?l=allergynotes.blogspot.com' alt='' /&gt;&lt;/div&gt;
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/atOVzoYVTa3g8cXbuw-Sk5Fd0Us/0/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/atOVzoYVTa3g8cXbuw-Sk5Fd0Us/0/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;br/&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/atOVzoYVTa3g8cXbuw-Sk5Fd0Us/1/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/atOVzoYVTa3g8cXbuw-Sk5Fd0Us/1/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/AllergyNotes/~4/CGSmzNT_ziM" height="1" width="1"/&gt;</content><link rel="replies" type="application/atom+xml" href="http://allergynotes.blogspot.com/feeds/7840365784742235236/comments/default" title="Post Comments" /><link rel="replies" type="text/html" href="http://allergynotes.blogspot.com/2009/11/allergy-and-immunology-news-of-day_21.html#comment-form" title="0 Comments" /><link rel="edit" type="application/atom+xml" href="http://www.blogger.com/feeds/2057269305378114997/posts/default/7840365784742235236?v=2" /><link rel="self" type="application/atom+xml" href="http://www.blogger.com/feeds/2057269305378114997/posts/default/7840365784742235236?v=2" /><link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/AllergyNotes/~3/CGSmzNT_ziM/allergy-and-immunology-news-of-day_21.html" title="Allergy and Immunology News of the Day" /><author><name>Ves Dimov, M.D.</name><email>noreply@blogger.com</email><gd:extendedProperty name="OpenSocialUserId" value="07511862151701001787" /></author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="http://3.bp.blogspot.com/_LY7APi0bufs/SXFDHrotv1I/AAAAAAAADTg/Jq_g36NjLeg/s72-c/Clock-2-small.jpg" height="72" width="72" /><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total><feedburner:origLink>http://allergynotes.blogspot.com/2009/11/allergy-and-immunology-news-of-day_21.html</feedburner:origLink></entry><entry gd:etag="W/&quot;AkAGQXw8cSp7ImA9WxNbF08.&quot;"><id>tag:blogger.com,1999:blog-2057269305378114997.post-5519260521105320741</id><published>2009-11-20T09:52:00.001-05:00</published><updated>2009-11-20T09:52:00.279-05:00</updated><app:edited xmlns:app="http://www.w3.org/2007/app">2009-11-20T09:52:00.279-05:00</app:edited><category scheme="http://www.blogger.com/atom/ns#" term="News of the Day" /><title>Allergy and Immunology News of the Day</title><content type="html">&lt;a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="http://3.bp.blogspot.com/_LY7APi0bufs/SXFDHrotv1I/AAAAAAAADTg/Jq_g36NjLeg/s1600-h/Clock-2-small.jpg"&gt;&lt;img style="margin: 0pt 0pt 10px 10px; float: right; cursor: pointer; width: 100px; height: 100px;" src="http://3.bp.blogspot.com/_LY7APi0bufs/SXFDHrotv1I/AAAAAAAADTg/Jq_g36NjLeg/s200/Clock-2-small.jpg" alt="" id="BLOGGER_PHOTO_ID_5292084836388683602" border="0" /&gt;&lt;/a&gt; &lt;a href="http://casesblog.blogspot.com/search/label/Health%20News%20of%20the%20Day"&gt;Health News of the Day&lt;/a&gt; is a daily summary made from the &lt;a href="https://twitter.com/Allergy"&gt;selected links I post on Twitter&lt;/a&gt;. It is in a bullet points format with links to the original sources which include 350 RSS feeds that produce about 2,500 items per day.&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;&lt;/span&gt;&lt;/span&gt;&lt;blockquote&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;Combined Immunodeficiency Associated with DOCK8 Mutations &lt;a href="http://bit.ly/RzeJ3" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/RzeJ3&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;Anaphylaxis after ingesting an omeprazole capsule - not due to omeprazole allergy but soybean oil hypersensitivity &lt;a href="http://bit.ly/1hndk1" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/1hndk1&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;A diagnosis of soy allergy should not be overlooked in cases of drug hypersensitivity &lt;a href="http://bit.ly/1hndk1" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/1hndk1&lt;/a&gt;&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;Large waist was associated with increased asthma prevalence even among women considered to have normal body weight &lt;a href="http://bit.ly/ppaCW" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/ppaCW&lt;/a&gt;&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;Intal Inhaler (cromolyn sodium inhalation aerosol) is discontinued, the company has not found a HFA MDI manufacturer &lt;a href="http://bit.ly/z1oBa" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/z1oBa&lt;/a&gt;&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;Urticaria pigmentosa on Flickr  &lt;a href="http://bit.ly/1jk23" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/1jk23&lt;/a&gt; via @&lt;a class="tweet-url username" href="http://twitter.com/MatthewBowdish"&gt;MatthewBowdish&lt;/a&gt;&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;Mother of a boy with food allergy is fighting the city's decision that park officials can't use EpiPen in emergencies &lt;a href="http://bit.ly/I94pe" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/I94pe&lt;/a&gt;&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;Allergen rules may alter scents of great perfumes &lt;a href="http://bit.ly/14kuFz" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/14kuFz&lt;/a&gt;&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;Contact dermatitis on Flickr: &lt;a href="http://bit.ly/3AqI29" class="tweet-url web" rel="nofollow" target="_blank"&gt;http://bit.ly/3AqI29&lt;/a&gt;&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class="status-body"&gt;&lt;span class="entry-content"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;/blockquote&gt;Medical news tweets are not research articles - they are 140-character messages - please always go to the original source, links, etc. Tweets and links do not represent endorsement, approval or support. Image source: OpenClipArt.org, public domain.&lt;br /&gt;&lt;br /&gt;&lt;a href="http://twitter.com/Allergy"&gt;Follow me&lt;/a&gt; on Twitter:&lt;br /&gt;&lt;br /&gt;&lt;script type="text/javascript" language="JavaScript" src="http://twittercounter.com/embed/?username=Allergy&amp;amp;style=bird"&gt;&lt;/script&gt;&lt;div class="blogger-post-footer"&gt;&lt;p&gt;   &lt;/p&gt;

Posted at &lt;a href="http://allergynotes.blogspot.com/"&gt;Allergy Notes&lt;/a&gt;. Stay updated and &lt;a href="http://feeds.feedburner.com/AllergyNotes"&gt;subscribe&lt;/a&gt;, or follow me on &lt;a href="http://twitter.com/Allergy"&gt;Twitter&lt;/a&gt;.&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2057269305378114997-5519260521105320741?l=allergynotes.blogspot.com' alt='' /&gt;&lt;/div&gt;
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/hE_7OLkmFx8nfY6aSbri7M6QWEw/0/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/hE_7OLkmFx8nfY6aSbri7M6QWEw/0/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;br/&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/hE_7OLkmFx8nfY6aSbri7M6QWEw/1/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/hE_7OLkmFx8nfY6aSbri7M6QWEw/1/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/AllergyNotes/~4/13CyewbCR-A" height="1" width="1"/&gt;</content><link rel="replies" type="application/atom+xml" href="http://allergynotes.blogspot.com/feeds/5519260521105320741/comments/default" title="Post Comments" /><link rel="replies" type="text/html" href="http://allergynotes.blogspot.com/2009/11/allergy-and-immunology-news-of-day_20.html#comment-form" title="0 Comments" /><link rel="edit" type="application/atom+xml" href="http://www.blogger.com/feeds/2057269305378114997/posts/default/5519260521105320741?v=2" /><link rel="self" type="application/atom+xml" href="http://www.blogger.com/feeds/2057269305378114997/posts/default/5519260521105320741?v=2" /><link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/AllergyNotes/~3/13CyewbCR-A/allergy-and-immunology-news-of-day_20.html" title="Allergy and Immunology News of the Day" /><author><name>Ves Dimov, M.D.</name><email>noreply@blogger.com</email><gd:extendedProperty name="OpenSocialUserId" value="07511862151701001787" /></author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="http://3.bp.blogspot.com/_LY7APi0bufs/SXFDHrotv1I/AAAAAAAADTg/Jq_g36NjLeg/s72-c/Clock-2-small.jpg" height="72" width="72" /><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total><feedburner:origLink>http://allergynotes.blogspot.com/2009/11/allergy-and-immunology-news-of-day_20.html</feedburner:origLink></entry><entry gd:etag="W/&quot;DE4EQX88fSp7ImA9WxNbF0w.&quot;"><id>tag:blogger.com,1999:blog-2057269305378114997.post-3039090275583847287</id><published>2009-11-20T06:35:00.001-05:00</published><updated>2009-11-20T06:35:00.175-05:00</updated><app:edited xmlns:app="http://www.w3.org/2007/app">2009-11-20T06:35:00.175-05:00</app:edited><category scheme="http://www.blogger.com/atom/ns#" term="Drug Trials" /><category scheme="http://www.blogger.com/atom/ns#" term="Angioedema" /><title>Subcutaneous kallikrein inhibitor ecallantide as a treatment for hereditary angioedema (HAE)</title><content type="html">From &lt;a href="http://www.medpagetoday.com/MeetingCoverage/ACAAI/16912"&gt;MedPage Today&lt;/a&gt;:&lt;br /&gt;&lt;br /&gt;Between 8,000 and 10,000 people in the U.S. are affected by the most common form of HAE which is caused by an autosomal dominant mutation that decreases C1 inhibitor levels.&lt;br /&gt;&lt;br /&gt;Plasma kallikrein plays a major role in the contact (kallikrein-kinin) cascade producing bradykinin. Bradykinin is a vasodilator, which increases vascular permeability, activates inflammation and produces pain.&lt;br /&gt;&lt;br /&gt;&lt;a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="http://2.bp.blogspot.com/_-Uzu0xg5lh0/R5a2BDkhs1I/AAAAAAAAAH0/z-gBaRg_wuQ/s1600-h/New_therapies_for_hereditary_angioedema_%28HAE%29.jpg"&gt;&lt;img style="cursor: pointer;" src="http://2.bp.blogspot.com/_-Uzu0xg5lh0/R5a2BDkhs1I/AAAAAAAAAH0/z-gBaRg_wuQ/s200/New_therapies_for_hereditary_angioedema_%28HAE%29.jpg" alt="" id="BLOGGER_PHOTO_ID_5158510552454116178" border="0" /&gt;&lt;/a&gt;&lt;br /&gt;New therapies for hereditary angioedema (HAE) (click to enlarge the image).&lt;br /&gt;&lt;br /&gt;Ecallantide (DX-88) is a subcutaneous kallikrein inhibitor which is under investigation for treatment of hereditary angioedema (HAE).&lt;br /&gt;&lt;br /&gt;In the clinical trials, the proportion of patients who said they had complete or near-complete resolution varied by attack site:&lt;br /&gt;&lt;br /&gt;- For abdominal attacks, 65.2% of those on the drug reported such an outcome, compared with 31.7% for those on placebo (P=0.01).&lt;br /&gt;&lt;br /&gt;- For laryngeal attacks, the comparable proportion were 60% versus 11.1% (P=0.03).&lt;br /&gt;&lt;br /&gt;- For peripheral attacks, there was no significant difference within the first four hours.&lt;br /&gt;&lt;br /&gt;However, the median times -- 67 minutes for the drug versus 105 minutes for placebo -- were not significantly different.&lt;br /&gt;&lt;br /&gt;References:&lt;br /&gt;&lt;a href="http://www.medpagetoday.com/MeetingCoverage/ACAAI/16912"&gt;ACAAI: HAE Drug Offers Faster Relief&lt;/a&gt;. Michael Smith, North American Correspondent, MedPage Today.&lt;br /&gt;&lt;a href="http://www.ncbi.nlm.nih.gov/pubmed/18613770"&gt;Ecallantide (DX-88), a plasma kallikrein inhibitor for the treatment of hereditary angioedema and the prevention of blood loss in on-pump cardiothoracic surgery&lt;/a&gt;. Lehmann A. Expert Opin Biol Ther. 2008 Aug;8(8):1187-99.&lt;div class="blogger-post-footer"&gt;&lt;p&gt;   &lt;/p&gt;

Posted at &lt;a href="http://allergynotes.blogspot.com/"&gt;Allergy Notes&lt;/a&gt;. Stay updated and &lt;a href="http://feeds.feedburner.com/AllergyNotes"&gt;subscribe&lt;/a&gt;, or follow me on &lt;a href="http://twitter.com/Allergy"&gt;Twitter&lt;/a&gt;.&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2057269305378114997-3039090275583847287?l=allergynotes.blogspot.com' alt='' /&gt;&lt;/div&gt;
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/n_AeBGuSz2KfbIGH-FiFUMZJ2yI/0/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/n_AeBGuSz2KfbIGH-FiFUMZJ2yI/0/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;br/&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/n_AeBGuSz2KfbIGH-FiFUMZJ2yI/1/da"&gt;&lt;img src="http://feedads.g.doubleclick.net/~a/n_AeBGuSz2KfbIGH-FiFUMZJ2yI/1/di" border="0" ismap="true"&gt;&lt;/img&gt;&lt;/a&gt;&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/AllergyNotes/~4/KAIY5ilKxm4" height="1" width="1"/&gt;</content><link rel="replies" type="application/atom+xml" href="http://allergynotes.blogspot.com/feeds/3039090275583847287/comments/default" title="Post Comments" /><link rel="replies" type="text/html" href="http://allergynotes.blogspot.com/2009/11/subcutaneous-kallikrein-inhibitor.html#comment-form" title="0 Comments" /><link rel="edit" type="application/atom+xml" href="http://www.blogger.com/feeds/2057269305378114997/posts/default/3039090275583847287?v=2" /><link rel="self" type="application/atom+xml" href="http://www.blogger.com/feeds/2057269305378114997/posts/default/3039090275583847287?v=2" /><link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/AllergyNotes/~3/KAIY5ilKxm4/subcutaneous-kallikrein-inhibitor.html" title="Subcutaneous kallikrein inhibitor ecallantide as a treatment for hereditary angioedema (HAE)" /><author><name>Ves Dimov, M.D.</name><email>noreply@blogger.com</email><gd:extendedProperty name="OpenSocialUserId" value="07511862151701001787" /></author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="http://2.bp.blogspot.com/_-Uzu0xg5lh0/R5a2BDkhs1I/AAAAAAAAAH0/z-gBaRg_wuQ/s72-c/New_therapies_for_hereditary_angioedema_%28HAE%29.jpg" height="72" width="72" /><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total><feedburner:origLink>http://allergynotes.blogspot.com/2009/11/subcutaneous-kallikrein-inhibitor.html</feedburner:origLink></entry></feed>
